Radiation Therapy
Information
- Drug Name
- Radiation Therapy
- Description
- Entry(CIViC)
- 2
CIViC
Disease | Mutation | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
head and neck squamous cell carcinoma | PIK3CA MUTATION PIK3CA MUTATION | D |
![]() |
![]() |
Sensitivity/Response | Somatic | 3 | 26589432 | Detail |
head and neck squamous cell carcinoma | CD274 EXPRESSION CD274 EXPRESSION | B |
![]() |
![]() |
Resistance |
![]() |
4 | 28476872 | Detail |
Annotation
Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
---|---|---|---|---|---|---|
A panel of 26 HNSCC cell lines was tested for effi... | PIK3CA | PIK3CA MUTATION PIK3CA MUTATION | Sensitivity | true | CIViC Evidence | detail |
Radiation-resistant cell lines exhibited upregulat... | CD274 | CD274 EXPRESSION CD274 EXPRESSION | Resitance or Non-Reponse | true | CIViC Evidence | detail |
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT01920932 | Active, not recruiting | Phase 2 | Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma | August 12, 2013 | May 2028 |
NCT01857934 | Active, not recruiting | Phase 2 | Therapy for Children With Advanced Stage Neuroblastoma | July 5, 2013 | December 2024 |
NCT02883049 | Active, not recruiting | Phase 3 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | February 29, 2012 | September 22, 2024 |
NCT04052555 | Active, not recruiting | Phase 1 | Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer | September 24, 2020 | November 20, 2024 |
NCT03904043 | Active, not recruiting | N/A | Non-Operative Management and Early Response Assessment in Rectal Cancer | July 1, 2020 | April 30, 2026 |
NCT01852890 | Active, not recruiting | Phase 1 | Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | January 2014 | January 2026 |
NCT02724579 | Active, not recruiting | Phase 2 | Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma | November 17, 2017 | June 30, 2027 |
NCT03829722 | Active, not recruiting | Phase 2 | Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer | September 5, 2019 | September 2024 |
NCT01849146 | Active, not recruiting | Phase 1 | Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma | August 19, 2013 | March 4, 2025 |
NCT01847326 | Active, not recruiting | Phase 1 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer | March 26, 2013 | November 4, 2027 |
NCT03809000 | Active, not recruiting | Phase 2 | A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery | April 15, 2019 | September 15, 2029 |
NCT03313804 | Active, not recruiting | Phase 2 | Priming Immunotherapy in Advanced Disease With Radiation | October 26, 2017 | February 2025 |
NCT01796197 | Active, not recruiting | Phase 2 | Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa | August 2013 | July 2024 |
NCT02698254 | Active, not recruiting | N/A | Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy | July 20, 2016 | July 1, 2025 |
NCT02679040 | Active, not recruiting | Phase 2 | Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy | January 27, 2016 | February 2025 |
NCT04047706 | Active, not recruiting | Phase 1 | Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma | August 13, 2019 | June 1, 2025 |
NCT02655601 | Active, not recruiting | Phase 2 | Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 | September 25, 2018 | December 2024 |
NCT02641093 | Active, not recruiting | Phase 2 | Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma | January 2016 | November 2, 2025 |
NCT04019262 | Active, not recruiting | Phase 1/Phase 2 | Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma | December 14, 2021 | July 2029 |
NCT04216290 | Active, not recruiting | Phase 2 | A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes (The INSPIRE Study) | March 17, 2021 | June 30, 2026 |
NCT04420975 | Active, not recruiting | Phase 1 | Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma | October 29, 2020 | January 31, 2026 |
NCT01752491 | Active, not recruiting | Phase 1 | A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme | April 1, 2013 | December 31, 2024 |
NCT04013542 | Active, not recruiting | Phase 1 | Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer | September 13, 2019 | December 31, 2024 |
NCT02626312 | Active, not recruiting | Phase 1 | Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function | February 15, 2016 | April 28, 2026 |
NCT01750073 | Active, not recruiting | Phase 2 | Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer | December 7, 2012 | June 2026 |
NCT02615275 | Active, not recruiting | N/A | Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy | November 24, 2015 | November 30, 2026 |
NCT01746238 | Active, not recruiting | Phase 1 | Bevacizumab/Doxorubicin/Radiation for Sarcoma | March 2013 | January 2025 |
NCT00005584 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | October 1998 | |
NCT01546987 | Active, not recruiting | Phase 3 | Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | May 2012 | June 2029 |
NCT03775265 | Active, not recruiting | Phase 3 | Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer | June 3, 2019 | June 1, 2027 |
NCT03738228 | Active, not recruiting | Phase 1 | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer | January 7, 2019 | September 21, 2024 |
NCT02567435 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma | June 1, 2016 | October 1, 2024 |
NCT03528642 | Active, not recruiting | Phase 1 | Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma | May 1, 2019 | December 5, 2024 |
NCT03517137 | Active, not recruiting | Phase 2 | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | August 1, 2019 | November 16, 2026 |
NCT03503630 | Active, not recruiting | Phase 2 | Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma | July 20, 2018 | July 2, 2024 |
NCT01517451 | Active, not recruiting | Phase 1/Phase 2 | Radiation and Androgen Ablation for Prostate Cancer | May 22, 2013 | December 2026 |
NCT01407198 | Active, not recruiting | Phase 1 | Nilotinib With Radiation for High Risk Chordoma | August 2011 | December 2025 |
NCT03307616 | Active, not recruiting | Phase 2 | Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery | October 4, 2017 | October 31, 2025 |
NCT01368588 | Active, not recruiting | Phase 3 | Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | July 2011 | July 2031 |
NCT02567422 | Active, not recruiting | Phase 1 | Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer | April 17, 2017 | April 23, 2025 |
NCT02525757 | Active, not recruiting | Phase 2 | MPDL3280A With Chemoradiation for Lung Cancer | January 26, 2016 | January 31, 2026 |
NCT04396860 | Active, not recruiting | Phase 2/Phase 3 | Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma | September 1, 2020 | March 11, 2025 |
NCT03491683 | Active, not recruiting | Phase 1/Phase 2 | INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) | May 31, 2018 | December 31, 2024 |
NCT01272050 | Active, not recruiting | Phase 3 | Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery | January 6, 2011 | December 2024 |
NCT02499367 | Active, not recruiting | Phase 2 | Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients | August 2015 | August 2025 |
NCT00002462 | Active, not recruiting | Phase 3 | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | September 1989 | |
NCT03725059 | Active, not recruiting | Phase 3 | Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) | December 27, 2018 | January 24, 2031 |
NCT02481635 | Active, not recruiting | Phase 1/Phase 2 | A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer | July 2016 | June 2024 |
NCT03999710 | Active, not recruiting | Phase 2 | Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer | July 19, 2019 | July 2025 |
NCT01165632 | Active, not recruiting | Early Phase 1 | Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma | July 26, 2010 | December 30, 2024 |
NCT03452930 | Active, not recruiting | Phase 1 | Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma | August 13, 2018 | December 30, 2024 |
NCT03935256 | Active, not recruiting | Phase 2 | Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer | March 5, 2019 | December 31, 2024 |
NCT02466971 | Active, not recruiting | Phase 3 | Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers | May 10, 2016 | September 21, 2024 |
NCT02444741 | Active, not recruiting | Phase 1/Phase 2 | Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | September 17, 2015 | September 30, 2025 |
NCT03681535 | Active, not recruiting | N/A | Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma | February 13, 2019 | August 2028 |
NCT02420613 | Active, not recruiting | Phase 1 | Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma | October 5, 2015 | October 31, 2024 |
NCT03916419 | Active, not recruiting | Phase 2 | Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer | June 20, 2019 | September 30, 2025 |
NCT03680586 | Active, not recruiting | Early Phase 1 | Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma | February 4, 2019 | April 30, 2025 |
NCT04376502 | Active, not recruiting | N/A | Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma. | April 8, 2020 | December 2024 |
NCT04183218 | Active, not recruiting | Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes | September 23, 2019 | September 23, 2025 | |
NCT02402920 | Active, not recruiting | Phase 1 | Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer | July 22, 2015 | July 31, 2025 |
NCT02352883 | Active, not recruiting | N/A | MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ | March 25, 2015 | November 2027 |
NCT00975520 | Active, not recruiting | N/A | Neurotropic Melanoma of the Head and Neck | September 2009 | March 2023 |
NCT03581292 | Active, not recruiting | Phase 2 | Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations | November 6, 2018 | September 22, 2024 |
NCT02344355 | Active, not recruiting | Phase 2 | A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme | March 13, 2017 | December 2027 |
NCT00945009 | Active, not recruiting | Phase 3 | Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor | July 13, 2009 | |
NCT05555342 | Active, not recruiting | Early Phase 1 | A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm | January 3, 2023 | December 2028 |
NCT02258659 | Active, not recruiting | Phase 2 | Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer | September 22, 2014 | December 2025 |
NCT00942357 | Active, not recruiting | Phase 3 | Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer | June 29, 2009 | July 28, 2024 |
NCT03422003 | Active, not recruiting | N/A | Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma | April 1, 2018 | April 1, 2030 |
NCT03306901 | Active, not recruiting | N/A | Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma | October 20, 2017 | December 31, 2033 |
NCT03279237 | Active, not recruiting | Phase 1 | A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers | October 24, 2017 | September 2023 |
NCT03548285 | Active, not recruiting | N/A | Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer | May 15, 2018 | December 2024 |
NCT03267498 | Active, not recruiting | Phase 2 | Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) | February 14, 2018 | April 30, 2024 |
NCT00846742 | Active, not recruiting | Phase 2 | Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma | June 5, 2009 | October 2028 |
NCT03228537 | Active, not recruiting | Phase 1 | Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma | July 16, 2018 | September 21, 2024 |
NCT04523818 | Active, not recruiting | Phase 1 | Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma | August 11, 2020 | December 31, 2028 |
NCT03217747 | Active, not recruiting | Phase 1/Phase 2 | Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies | August 2, 2017 | September 30, 2024 |
NCT00769223 | Active, not recruiting | Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer | February 25, 1993 | January 31, 2025 | |
NCT03416153 | Active, not recruiting | Phase 2 | Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer | May 21, 2018 | May 2024 |
NCT03414970 | Active, not recruiting | Phase 3 | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer | March 12, 2018 | August 2035 |
NCT03217266 | Active, not recruiting | Phase 1 | Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma | June 20, 2018 | February 28, 2025 |
NCT04298983 | Active, not recruiting | Phase 2 | Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer | February 25, 2021 | April 2026 |
NCT00707473 | Active, not recruiting | Phase 2 | Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer | June 16, 2008 | September 30, 2025 |
NCT04174196 | Active, not recruiting | Phase 2 | A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma | November 19, 2019 | November 19, 2024 |
NCT03174197 | Active, not recruiting | Phase 1/Phase 2 | Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | June 30, 2017 | June 30, 2025 |
NCT04484909 | Active, not recruiting | Phase 1 | NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer | July 1, 2020 | December 31, 2026 |
NCT04522336 | Active, not recruiting | Phase 1 | Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer | September 16, 2020 | July 18, 2024 |
NCT02959463 | Active, not recruiting | Phase 1 | Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma | May 1, 2017 | April 30, 2024 |
NCT00626990 | Active, not recruiting | Phase 3 | Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) | December 2007 | December 2029 |
NCT02186847 | Active, not recruiting | Phase 2 | Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer | August 2014 | April 16, 2025 |
NCT02180867 | Active, not recruiting | Phase 2/Phase 3 | Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery | July 11, 2014 | December 22, 2024 |
NCT02177292 | Active, not recruiting | N/A | High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB) | June 23, 2010 | December 2026 |
NCT02954874 | Active, not recruiting | Phase 3 | Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer | January 18, 2017 | May 31, 2026 |
NCT00554788 | Active, not recruiting | Phase 3 | Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma | February 4, 2008 | December 31, 2024 |
NCT00066690 | Active, not recruiting | Phase 3 | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer | December 17, 2003 | December 2025 |
NCT03410901 | Active, not recruiting | Phase 1 | TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas | April 9, 2018 | October 10, 2024 |
NCT02114229 | Active, not recruiting | Phase 2 | Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors | May 14, 2014 | September 2027 |
NCT04220229 | Active, not recruiting | Phase 1/Phase 2 | Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities | June 1, 2020 | January 23, 2027 |
NCT04481204 | Active, not recruiting | Phase 2 | New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study | April 18, 2023 | April 6, 2025 |
NCT02112916 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma | October 4, 2014 | September 22, 2024 |
NCT04581382 | Active, not recruiting | Early Phase 1 | Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma | December 14, 2020 | October 31, 2024 |
NCT00544414 | Active, not recruiting | Phase 2 | Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer | June 7, 2000 | December 30, 2024 |
NCT00508443 | Active, not recruiting | Phase 1/Phase 2 | Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) | October 25, 2002 | October 31, 2026 |
NCT00476190 | Active, not recruiting | Phase 2 | ALL Adult Consortium Trial: Adult ALL Trial | April 2007 | December 2024 |
NCT03907488 | Active, not recruiting | Phase 3 | Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma | August 29, 2019 | April 1, 2025 |
NCT02101853 | Active, not recruiting | Phase 3 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | December 17, 2014 | September 22, 2024 |
NCT02037048 | Active, not recruiting | Phase 2 | FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma | February 10, 2014 | October 1, 2025 |
NCT00411138 | Active, not recruiting | Phase 3 | Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer | November 23, 2006 | December 31, 2024 |
NCT02023463 | Active, not recruiting | Phase 1 | Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer | April 2, 2014 | January 1, 2040 |
NCT02923778 | Active, not recruiting | Phase 2 | Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery | December 31, 2019 | December 1, 2024 |
NCT00408005 | Active, not recruiting | Phase 3 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma | January 22, 2007 | March 7, 2025 |
NCT03410043 | Active, not recruiting | Phase 2 | Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study | January 17, 2018 | June 1, 2025 |
NCT01972919 | Active, not recruiting | Phase 2 | Magnetic Resonance (MR) Guided, Dose-Escalated Radiation Therapy (RT) + Chemotherapy in Pancreatic Cancer | December 10, 2015 | December 2024 |
NCT04460937 | Active, not recruiting | Phase 1 | Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers | April 9, 2021 | October 31, 2024 |
NCT00392327 | Active, not recruiting | Phase 3 | Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET | March 26, 2007 | January 30, 2025 |
NCT05108428 | Active, not recruiting | Early Phase 1 | Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma | December 23, 2021 | October 2026 |
NCT00379041 | Active, not recruiting | Phase 3 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma | September 1, 1993 | |
NCT00335816 | Active, not recruiting | Phase 2 | Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | August 2008 | December 2024 |
NCT00077285 | Active, not recruiting | Phase 2 | Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | October 2003 | October 2024 |
NCT03359954 | Active, not recruiting | Phase 2 | Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer | November 16, 2017 | October 31, 2025 |
NCT03532295 | Active, not recruiting | Phase 2 | Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas | April 20, 2020 | April 25, 2026 |
NCT00334815 | Active, not recruiting | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | June 15, 2006 | February 22, 2025 |
NCT05190315 | Active, not recruiting | Phase 1 | Chlorpromazine and Standard of Care in Glioblastoma | January 28, 2022 | July 2024 |
NCT04580771 | Active, not recruiting | Phase 2 | A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial | October 14, 2020 | March 8, 2025 |
NCT04575922 | Active, not recruiting | Phase 2 | Nivolumab+Ipilimumab+RT in MSS mCRC | October 5, 2020 | June 2024 |
NCT00310180 | Active, not recruiting | Phase 3 | Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) | April 7, 2006 | September 30, 2030 |
NCT00182728 | Active, not recruiting | N/A | Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer | March 18, 2003 | July 2, 2027 |
NCT00107198 | Active, not recruiting | Phase 2 | Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease | January 2, 2006 | December 31, 2030 |
NCT04905316 | Active, not recruiting | Phase 2 | A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer | May 21, 2021 | May 2025 |
NCT06110195 | Active, not recruiting | Phase 1 | Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer | January 24, 2024 | October 2027 |
NCT02888743 | Active, not recruiting | Phase 2 | Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer | August 14, 2017 | January 2, 2025 |
NCT00085735 | Active, not recruiting | Phase 3 | Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma | April 2004 | |
NCT05320406 | Active, not recruiting | Phase 4 | RElugolix VErsus LeUprolide Cardiac Trial | June 6, 2022 | January 30, 2026 |
NCT00003375 | Completed | Phase 2/Phase 3 | Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma | October 1998 | May 14, 2018 |
NCT00003377 | Completed | Phase 1 | Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix | November 1999 | July 2009 |
NCT00003379 | Completed | Phase 1/Phase 2 | Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer | November 1999 | |
NCT00003387 | Completed | Phase 3 | Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | July 1998 | April 2009 |
NCT00003388 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | July 26, 1999 | |
NCT00003396 | Completed | Phase 2 | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | September 1998 | December 2002 |
NCT00003398 | Completed | Phase 4 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | September 1998 | May 2000 |
NCT00003409 | Completed | Phase 1 | Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | July 1998 | |
NCT00003411 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | November 1998 | June 2002 |
NCT00003414 | Completed | Phase 3 | Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease | October 1997 | May 2004 |
NCT00003417 | Completed | Phase 1/Phase 2 | Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme | September 1998 | |
NCT00003421 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | June 1998 | November 2005 |
NCT00003422 | Completed | Phase 3 | Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | January 1998 | June 2010 |
NCT00003426 | Completed | Phase 1 | Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | April 1998 | March 2002 |
NCT00003444 | Completed | Phase 3 | Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin | March 29, 1999 | |
NCT00003464 | Completed | Phase 2 | Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme | September 1997 | August 2003 |
NCT00003478 | Completed | Phase 1/Phase 2 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors | October 1997 | July 2007 |
NCT00003541 | Completed | Phase 1/Phase 2 | Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | June 1998 | July 2006 |
NCT00003546 | Completed | Phase 2 | Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | September 1998 | January 2006 |
NCT00003572 | Completed | Phase 2 | Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers | August 1998 | April 2002 |
NCT00003573 | Completed | Phase 2 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | November 1998 | March 2008 |
NCT00003576 | Completed | Phase 3 | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery | January 1997 | August 2005 |
NCT00003577 | Completed | Phase 3 | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | March 1996 | September 2008 |
NCT00003580 | Completed | Phase 2 | Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer | June 1998 | May 2004 |
NCT00003582 | Completed | Phase 1/Phase 2 | Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer | May 1988 | December 1996 |
NCT00003591 | Completed | Phase 2 | Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer | November 1998 | October 2005 |
NCT00003596 | Completed | Phase 3 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | October 1998 | December 2016 |
NCT00003606 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer | March 1996 | June 2001 |
NCT00003607 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | December 1997 | January 2015 |
NCT00003610 | Completed | Phase 3 | Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy | October 1998 | July 2006 |
NCT00003621 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma | February 1999 | July 2005 |
NCT00003625 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | December 1998 | April 2006 |
NCT00003627 | Completed | Phase 3 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx | October 1998 | January 2011 |
NCT00003631 | Completed | Phase 2 | Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | August 1998 | |
NCT00003650 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | February 1997 | November 2013 |
NCT00003652 | Completed | Phase 3 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | January 4, 1999 | March 31, 2007 |
NCT00003661 | Completed | Phase 2 | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | June 1998 | March 2006 |
NCT00003662 | Completed | Phase 2 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases | August 1998 | January 2001 |
NCT00003667 | Completed | Phase 2 | Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma | September 1998 | August 2000 |
NCT00003685 | Completed | Phase 3 | Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer | August 1, 1997 | February 10, 2009 |
NCT00003704 | Completed | Phase 1 | Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | April 1999 | July 2003 |
NCT00003749 | Completed | Phase 3 | Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer | April 1998 | December 2008 |
NCT00003751 | Completed | Phase 2 | Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma | March 1999 | July 2005 |
NCT00003783 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | March 1999 | March 2007 |
NCT00003798 | Completed | Phase 1 | Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery | April 2000 | |
NCT00003799 | Completed | Phase 1 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer | May 1999 | |
NCT00003812 | Completed | Phase 2 | Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | March 1999 | March 2006 |
NCT00003846 | Completed | Phase 2 | Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | July 1999 | March 2007 |
NCT00003857 | Completed | Phase 3 | Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ | December 1999 | May 20, 2022 |
NCT00003859 | Completed | Phase 3 | Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS | April 1992 | April 2003 |
NCT00003862 | Completed | Phase 2 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | November 1999 | |
NCT00003868 | Completed | Phase 2 | Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia | February 1999 | March 2005 |
NCT00003870 | Completed | Phase 2 | Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia | February 1999 | November 2001 |
NCT00003888 | Completed | Phase 3 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | April 1999 | March 2015 |
NCT00003893 | Completed | Phase 3 | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | July 1998 | April 2006 |
NCT00003909 | Completed | Phase 1 | Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | August 1999 | |
NCT00003913 | Completed | Phase 2 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease | December 1998 | August 2005 |
NCT00003916 | Completed | Phase 3 | Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma | April 1999 | |
NCT00003930 | Completed | Phase 1/Phase 2 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | September 1999 | November 2013 |
NCT00003935 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | September 1999 | March 2007 |
NCT00003953 | Completed | Phase 2 | Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | February 1999 | January 2013 |
NCT00003955 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma | September 1999 | October 2009 |
NCT00003958 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma | September 2002 | |
NCT00003972 | Completed | Phase 3 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer | July 1998 | March 2003 |
NCT00003996 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | May 1999 | May 2008 |
NCT00004005 | Completed | Phase 2 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | September 1998 | October 2005 |
NCT00004006 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | November 1997 | September 2005 |
NCT00004010 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | October 1999 | June 2008 |
NCT00004024 | Completed | Phase 2 | Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma | June 1997 | January 2004 |
NCT00004031 | Completed | Phase 3 | SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma | July 1997 | October 31, 2013 |
NCT00004054 | Completed | Phase 3 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | January 2000 | November 2013 |
NCT00004061 | Completed | Phase 2 | Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer | May 1999 | December 2009 |
NCT00004068 | Completed | Phase 2 | Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor | March 1999 | April 2003 |
NCT00004073 | Completed | Phase 2 | Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | December 1999 | June 2004 |
NCT00004089 | Completed | Phase 2 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | August 1999 | April 2002 |
NCT00004125 | Completed | Phase 3 | Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes | November 16, 1999 | November 2016 |
NCT00004132 | Completed | Phase 2 | Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer | January 2000 | May 2004 |
NCT00004146 | Completed | Phase 2 | Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM | March 2000 | January 2010 |
NCT00004160 | Completed | Phase 1/Phase 2 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed | February 2000 | May 2004 |
NCT00004169 | Completed | Phase 2 | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease | November 1993 | January 2007 |
NCT00004172 | Completed | Phase 2 | Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | October 1999 | October 2003 |
NCT00004174 | Completed | Phase 1 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer | October 1999 | May 2008 |
NCT00004176 | Completed | Phase 2 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | October 1998 | February 2001 |
NCT00004181 | Completed | Phase 2 | Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia | October 1999 | August 2004 |
NCT00004186 | Completed | Phase 1/Phase 2 | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | December 1996 | December 2004 |
NCT00004188 | Completed | Phase 3 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | February 2001 | |
NCT00004202 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer | October 1998 | January 2003 |
NCT00004224 | Completed | Phase 2 | Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma | January 1999 | March 2008 |
NCT00004225 | Completed | Phase 1 | Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | January 2000 | |
NCT00004228 | Completed | Phase 3 | Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma | June 2000 | March 31, 2015 |
NCT00004230 | Completed | Phase 3 | Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation | October 1999 | March 2002 |
NCT00004234 | Completed | Phase 3 | Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx | August 2, 1999 | February 10, 2009 |
NCT00004237 | Completed | Phase 2 | Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer | October 1998 | September 2005 |
NCT00004255 | Completed | Phase 2/Phase 3 | Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation | March 2000 | May 2003 |
NCT00004256 | Completed | Phase 2 | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | October 1997 | July 2006 |
NCT00004257 | Completed | Phase 1 | Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | January 2000 | January 2004 |
NCT00004259 | Completed | Phase 3 | Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas | June 2000 | May 14, 2018 |
NCT00004891 | Completed | N/A | PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery | September 1999 | |
NCT00004896 | Completed | Phase 2 | Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | October 1999 | August 2004 |
NCT00004898 | Completed | Phase 1/Phase 2 | Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | October 1999 | July 2003 |
NCT00004900 | Completed | Phase 2 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | October 1999 | August 2004 |
NCT00004901 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | October 1999 | July 2004 |
NCT00004905 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | October 1999 | September 2004 |
NCT00004907 | Completed | Phase 1/Phase 2 | Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma | October 1999 | August 2004 |
NCT00004908 | Completed | Phase 2 | Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | November 1999 | June 2002 |
NCT00004917 | Completed | Phase 3 | Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer | June 2000 | December 2016 |
NCT00005022 | Completed | Phase 1 | Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | February 1998 | June 2010 |
NCT00005044 | Completed | Phase 3 | Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | February 2000 | May 20, 2022 |
NCT00005062 | Completed | Phase 3 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | September 1999 | December 2005 |
NCT00005065 | Completed | Phase 1 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | January 2000 | |
NCT00005087 | Completed | Phase 2 | Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer | March 2000 | November 2013 |
NCT00005088 | Completed | Phase 2 | Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer | April 2000 | |
NCT00005089 | Completed | Phase 2 | S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma | April 2000 | April 2014 |
NCT00005578 | Completed | Phase 3 | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | March 1997 | June 2008 |
NCT00005583 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer | January 2000 | July 2010 |
NCT00005587 | Completed | Phase 3 | Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer | January 1999 | June 2004 |
NCT00005588 | Completed | Phase 3 | Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer | January 1999 | December 2004 |
NCT00005602 | Completed | Phase 1 | Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas | February 2001 | September 2005 |
NCT00005615 | Completed | Phase 1/Phase 2 | Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa | July 1997 | December 2005 |
NCT00005638 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | October 1999 | April 2004 |
NCT00005801 | Completed | Phase 2 | Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia | November 1999 | September 2001 |
NCT00005802 | Completed | Phase 1/Phase 2 | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia | June 1999 | March 2005 |
NCT00005804 | Completed | Phase 2 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | October 1999 | August 2002 |
NCT00005814 | Completed | Phase 2 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer | December 1999 | October 2005 |
NCT00005822 | Completed | Phase 1 | SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | April 2000 | October 2003 |
NCT00005830 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | July 2000 | |
NCT00005838 | Completed | Phase 3 | Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | March 2000 | |
NCT00005840 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | July 2000 | |
NCT00005854 | Completed | Phase 2 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | December 1999 | October 2000 |
NCT00005866 | Completed | Phase 3 | S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia | February 2000 | March 2006 |
NCT00005887 | Completed | Phase 3 | Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases | February 2000 | January 2003 |
NCT00005926 | Completed | Phase 2 | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | June 2000 | December 2000 |
NCT00005941 | Completed | Phase 2 | Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer | November 1999 | June 2005 |
NCT00005945 | Completed | Phase 3 | Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia | June 2000 | June 2008 |
NCT00005978 | Completed | Phase 1 | N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | May 2000 | |
NCT00005985 | Completed | Phase 2 | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | August 2000 | February 2007 |
NCT00005988 | Completed | Phase 1 | Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy | February 2000 | March 8, 2002 |
NCT00006012 | Completed | Phase 1/Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | February 2001 | May 2006 |
NCT00006027 | Completed | Phase 3 | Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer | August 2000 | |
NCT00006042 | Completed | Phase 1 | Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | December 1999 | |
NCT00006051 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | February 1999 | September 2005 |
NCT00006107 | Completed | Phase 1 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | July 14, 2000 | July 3, 2004 |
NCT00006111 | Completed | Phase 2 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | April 1999 | June 2008 |
NCT00006231 | Completed | Phase 3 | Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma | February 1998 | December 2002 |
NCT00006233 | Completed | Phase 2 | Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma | January 2000 | December 2003 |
NCT00006241 | Completed | Phase 2 | Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma | March 2000 | October 2000 |
NCT00006256 | Completed | Phase 2 | Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer | June 8, 2000 | November 20, 2023 |
NCT00006258 | Completed | Phase 2 | Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | November 1997 | January 2005 |
NCT00006353 | Completed | Phase 3 | Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | July 2000 | |
NCT00006355 | Completed | Phase 1/Phase 2 | Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme | May 2000 | October 2006 |
NCT00006359 | Completed | Phase 2 | Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer | September 2000 | March 2012 |
NCT00006360 | Completed | Phase 1/Phase 2 | Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer | February 2001 | December 2016 |
NCT00006365 | Completed | Phase 2 | External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer | November 2000 | November 2013 |
NCT00006366 | Completed | Phase 2 | Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | February 2001 | |
NCT00006378 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | December 1999 | April 2003 |
NCT00006386 | Completed | Phase 2 | Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme | March 2001 | February 2009 |
NCT00006388 | Completed | Phase 2 | Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme | December 2000 | |
NCT00006390 | Completed | Phase 2 | Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | July 5, 2001 | |
NCT00006452 | Completed | Phase 1 | Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme | April 10, 2002 | March 16, 2004 |
NCT00006469 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer | August 1999 | January 30, 2006 |
NCT00006470 | Completed | Phase 2 | Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery | March 2001 | |
NCT00006481 | Completed | Phase 3 | Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer | October 2000 | |
NCT00006487 | Completed | Phase 1 | S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | October 2000 | July 2004 |
NCT00006734 | Completed | Phase 3 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor | May 2001 | June 30, 2023 |
NCT00007904 | Completed | Phase 2 | Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes | July 2000 | September 2012 |
NCT00008151 | Completed | Phase 2 | Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome | October 2000 | July 2002 |
NCT00008398 | Completed | Phase 3 | Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | October 2000 | |
NCT00009880 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | April 2001 | |
NCT00010036 | Completed | Phase 2 | Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme | May 1999 | |
NCT00010166 | Completed | Phase 2 | Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas | December 1, 2000 | October 3, 2003 |
NCT00010244 | Completed | Phase 3 | Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer | September 1999 | March 2018 |
NCT00011778 | Completed | Phase 1 | PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck | February 22, 2001 | February 8, 2013 |
NCT00011960 | Completed | Phase 2 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | May 2001 | |
NCT00011999 | Completed | Phase 2 | Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer | March 2001 | June 2010 |
NCT00012051 | Completed | Phase 3 | Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | September 2000 | October 2007 |
NCT00014118 | Completed | Phase 2 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer | June 6, 2001 | May 2009 |
NCT00014612 | Completed | Phase 3 | Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer | February 2001 | March 2013 |
NCT00016211 | Completed | Phase 3 | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer | February 2001 | |
NCT00016302 | Completed | N/A | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | April 2001 | |
NCT00016315 | Completed | Phase 1 | Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer | May 2001 | June 2010 |
NCT00016913 | Completed | Phase 2 | Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | May 2001 | May 2008 |
NCT00017095 | Completed | Phase 3 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | March 2001 | |
NCT00017147 | Completed | Phase 3 | S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma | September 2001 | November 2012 |
NCT00017225 | Completed | Phase 2 | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | May 1997 | February 2002 |
NCT00017368 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | April 2001 | January 2012 |
NCT00018954 | Completed | Phase 2 | Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | October 1992 | October 2002 |
NCT00019058 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Glioblastoma | April 1995 | |
NCT00019071 | Completed | Phase 1 | Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma | March 1995 | |
NCT00020709 | Completed | Phase 3 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | June 2001 | |
NCT00020891 | Completed | Phase 2 | CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy | March 2001 | |
NCT00021125 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Head and Neck Cancer | July 2000 | June 2007 |
NCT00021320 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | May 2000 | April 2009 |
NCT00021333 | Completed | Phase 2 | Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer | September 1999 | May 2008 |
NCT00021398 | Completed | Phase 2 | Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer | July 1996 | September 2018 |
NCT00021450 | Completed | Phase 3 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | April 2001 | January 2016 |
NCT00022126 | Completed | Phase 2 | Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia | November 2002 | April 2006 |
NCT00022139 | Completed | Phase 2 | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | January 2002 | January 2009 |
NCT00022256 | Completed | Phase 2 | Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | April 2001 | April 2003 |
NCT00022308 | Completed | Phase 1 | Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | January 1999 | September 2006 |
NCT00022737 | Completed | Phase 3 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | October 2002 | |
NCT00023660 | Completed | Phase 1/Phase 2 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | August 2001 | |
NCT00023725 | Completed | Phase 1/Phase 2 | Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma | August 2001 | October 2003 |
NCT00023738 | Completed | Phase 1/Phase 2 | Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | August 2001 | October 2003 |
NCT00023751 | Completed | Phase 2 | Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer | July 2001 | April 2004 |
NCT00023829 | Completed | Phase 3 | Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer | August 2001 | June 2004 |
NCT00023959 | Completed | Phase 1 | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | July 2001 | |
NCT00023998 | Completed | Phase 2 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | July 2001 | May 2007 |
NCT00024349 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | June 2001 | April 2012 |
NCT00025038 | Completed | Phase 2 | Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia | June 2001 | |
NCT00025077 | Completed | Phase 2 | Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors | January 2000 | April 2011 |
NCT00025090 | Completed | Phase 3 | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer | March 2001 | August 2007 |
NCT00025168 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | November 1, 2001 | August 29, 2003 |
NCT00025272 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | November 1, 2001 | January 18, 2005 |
NCT00025441 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors | November 1998 | March 2010 |
NCT00025480 | Completed | Phase 1 | Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | August 2001 | |
NCT00025545 | Completed | Phase 2 | Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p> | March 1996 | October 2002 |
NCT00026104 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer | November 2001 | |
NCT00026130 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | September 2001 | June 2010 |
NCT00026377 | Completed | Phase 1 | SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | November 2001 | April 2003 |
NCT00026403 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | September 2001 | July 2009 |
NCT00027547 | Completed | Phase 1/Phase 2 | Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | July 2001 | July 2004 |
NCT00027612 | Completed | Phase 1/Phase 2 | Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme | July 2002 | July 2009 |
NCT00027846 | Completed | Phase 2 | Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma | August 2003 | March 31, 2016 |
NCT00027885 | Completed | Phase 2 | Phase II Bevacizumab + Tax In Advanced Breast Cancer | November 2001 | August 2010 |
NCT00028665 | Completed | Phase 2 | Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma | June 2000 | |
NCT00028678 | Completed | Phase 2 | Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme | July 11, 2002 | June 2007 |
NCT00028730 | Completed | Phase 2 | Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer | August 2001 | June 2008 |
NCT00028795 | Completed | Phase 2 | Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma | December 2002 | March 2012 |
NCT00028938 | Completed | Phase 3 | Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | January 1, 2002 | November 10, 2002 |
NCT00030628 | Completed | Phase 3 | Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | December 2001 | October 2014 |
NCT00030680 | Completed | Phase 2 | Radiation Therapy in Treating Patients With Aggressive Fibromatoses | November 2001 | March 2012 |
NCT00031668 | Completed | N/A | Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation | January 31, 2001 | February 10, 2009 |
NCT00031785 | Completed | Phase 3 | Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer | September 1, 2000 | September 11, 2002 |
NCT00031967 | Completed | Phase 2 | Melatonin and Radiation Therapy in Treating Patients With Brain Metastases | May 2002 | |
NCT00032006 | Completed | Phase 2 | Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer | February 2002 | October 2003 |
NCT00032032 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | May 2002 | January 2010 |
NCT00032097 | Completed | Phase 1 | Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain | April 2002 | |
NCT00033254 | Completed | Phase 3 | Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases | March 2002 | |
NCT00033280 | Completed | Phase 2 | Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas | July 2002 | May 14, 2018 |
NCT00033410 | Completed | Phase 1 | Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | March 2002 | |
NCT00033436 | Completed | Phase 3 | Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer | October 2000 | November 2008 |
NCT00033553 | Completed | Phase 2 | Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer | March 2002 | June 2010 |
NCT00033657 | Completed | Phase 2 | Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer | August 15, 2002 | October 2009 |
NCT00033696 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | September 2001 | April 2009 |
NCT00039195 | Completed | Phase 2 | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma | November 2006 | January 2010 |
NCT00039351 | Completed | Phase 2 | Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma | March 2002 | |
NCT00040365 | Completed | Phase 2 | Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer | June 2002 | June 2011 |
NCT00040482 | Completed | Phase 2 | High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis | April 1999 | August 2005 |
NCT00040690 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | November 2008 | December 2008 |
NCT00040794 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | May 2002 | |
NCT00040872 | Completed | Phase 2 | Multiple Therapies in Treating Patients With Advanced Neuroblastoma | June 2000 | January 2007 |
NCT00042367 | Completed | N/A | Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors | April 4, 2000 | June 2006 |
NCT00042991 | Completed | Phase 1/Phase 2 | Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas | July 2002 | March 2010 |
NCT00043108 | Completed | Phase 2 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | July 2002 | February 2018 |
NCT00044954 | Completed | Phase 2 | Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | November 1999 | November 2006 |
NCT00045565 | Completed | Phase 1 | Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma | October 2002 | |
NCT00046839 | Completed | Phase 1/Phase 2 | Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | July 2002 | |
NCT00046969 | Completed | Phase 4 | Epoetin Beta in Treating Anemia in Patients With Cervical Cancer | July 2002 | June 2007 |
NCT00047099 | Completed | Phase 3 | Combination Chemotherapy in Treating Women With Breast Cancer | August 2001 | March 2012 |
NCT00047112 | Completed | Phase 3 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | May 2002 | September 2010 |
NCT00047125 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor | July 2002 | |
NCT00047320 | Completed | Phase 2 | Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors | January 2004 | February 2009 |
NCT00048997 | Completed | Phase 3 | Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer | September 2002 | December 2016 |
NCT00049283 | Completed | Phase 1 | Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | September 2002 | February 2008 |
NCT00049348 | Completed | Phase 2 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | October 13, 2003 | May 2009 |
NCT00049361 | Completed | Phase 2 | Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases | January 1, 2004 | December 7, 2004 |
NCT00049387 | Completed | Phase 1 | Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | September 2002 | June 2007 |
NCT00052208 | Completed | Phase 1/Phase 2 | Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme | March 2002 | |
NCT00052351 | Completed | Phase 2 | Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | September 2002 | October 2007 |
NCT00052429 | Completed | Phase 1/Phase 2 | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | September 2002 | November 2010 |
NCT00052910 | Completed | Phase 3 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | December 2002 | December 2016 |
NCT00052923 | Completed | Phase 3 | Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma | March 2003 | |
NCT00052936 | Completed | Phase 3 | Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma | January 2001 | August 5, 2010 |
NCT00053183 | Completed | Phase 1 | Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | October 2003 | |
NCT00053768 | Completed | Phase 3 | Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | April 2002 | December 5, 2006 |
NCT00053898 | Completed | Phase 3 | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy | January 2003 | May 2016 |
NCT00054054 | Completed | Phase 2 | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer | April 2003 | |
NCT00054327 | Completed | Phase 2 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer | November 2000 | September 2011 |
NCT00055601 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | December 2002 | May 14, 2018 |
NCT00055653 | Completed | Phase 2 | Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders | January 2003 | September 2005 |
NCT00055731 | Completed | Phase 3 | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | November 14, 2002 | December 31, 2022 |
NCT00055835 | Completed | Phase 2 | S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium | November 2002 | June 2006 |
NCT00057876 | Completed | Phase 3 | Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer | August 29, 2003 | May 2009 |
NCT00058097 | Completed | Phase 2 | Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | August 2003 | |
NCT00058370 | Completed | N/A | Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma | February 2003 | June 2019 |
NCT00059761 | Completed | Phase 1 | Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | March 2003 | November 2013 |
NCT00059826 | Completed | Phase 2 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | March 2003 | February 2011 |
NCT00060255 | Completed | Phase 2 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | December 1991 | February 2013 |
NCT00060333 | Completed | Phase 2 | Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma | July 2003 | April 2016 |
NCT00061893 | Completed | Phase 2 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | April 2004 | December 2013 |
NCT00062140 | Completed | Phase 1 | Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer | April 2003 | July 2004 |
NCT00062270 | Completed | Phase 1/Phase 2 | Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | May 2003 | September 2004 |
NCT00062309 | Completed | Phase 3 | Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer | June 2002 | |
NCT00062322 | Completed | Phase 1 | Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer | February 2003 | October 2009 |
NCT00062439 | Completed | Phase 2 | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors | July 2003 | December 2010 |
NCT00063947 | Completed | Phase 1 | Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | May 2003 | |
NCT00064207 | Completed | Phase 2/Phase 3 | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | May 2003 | |
NCT00066222 | Completed | Phase 2 | Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | June 2003 | November 2013 |
NCT00066742 | Completed | Phase 2 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | September 2003 | August 2009 |
NCT00067015 | Completed | Phase 3 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | May 2003 | September 2008 |
NCT00068250 | Completed | Phase 1/Phase 2 | Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma | July 2003 | December 2016 |
NCT00068263 | Completed | Phase 1/Phase 2 | 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection | August 2003 | December 2016 |
NCT00068549 | Completed | Phase 1 | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | October 2003 | |
NCT00068575 | Completed | Phase 2 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | May 2002 | December 2010 |
NCT00069953 | Completed | Phase 2 | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | September 2003 | December 2016 |
NCT00070018 | Completed | Phase 2 | S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma | February 2004 | January 8, 2015 |
NCT00070200 | Completed | Phase 1 | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | March 2004 | December 2013 |
NCT00072527 | Completed | Phase 2 | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | November 2003 | January 2013 |
NCT00074152 | Completed | Phase 3 | Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer | July 2002 | August 22, 2016 |
NCT00075582 | Completed | Phase 3 | Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma | September 4, 2004 | September 30, 2021 |
NCT00075725 | Completed | Phase 3 | Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia | December 29, 2003 | March 31, 2021 |
NCT00077051 | Completed | Phase 1 | Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) | April 2004 | July 2007 |
NCT00077116 | Completed | Phase 2 | Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome | November 2003 | |
NCT00077519 | Completed | Phase 1 | Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer | January 2004 | December 31, 2019 |
NCT00079339 | Completed | Phase 1/Phase 2 | Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma | January 2004 | November 2009 |
NCT00079417 | Completed | Phase 3 | Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma | December 26, 2005 | March 31, 2017 |
NCT00080912 | Completed | N/A | Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases | January 22, 2004 | January 16, 2014 |
NCT00080938 | Completed | Phase 2 | Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer | December 20, 2005 | February 2009 |
NCT00081289 | Completed | Phase 2 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | March 2004 | December 2016 |
NCT00081302 | Completed | Phase 2 | Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | March 2004 | November 2013 |
NCT00083057 | Completed | Phase 1 | Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | May 2004 | November 2010 |
NCT00084318 | Completed | Phase 2 | Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck | April 2004 | December 2016 |
NCT00002459 | Completed | Phase 3 | Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus | April 1988 | |
NCT00002461 | Completed | Phase 2 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | April 1988 | July 1991 |
NCT00002466 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer | May 1990 | May 2005 |
NCT00002472 | Completed | Phase 2 | Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors | March 1991 | August 2005 |
NCT00002476 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | January 1990 | January 2010 |
NCT00002480 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Prostate Cancer | February 1991 | August 2005 |
NCT00002484 | Completed | Phase 1 | Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer | October 1991 | |
NCT00002490 | Completed | Phase 3 | Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer | September 1991 | |
NCT00002492 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma | November 1991 | February 2000 |
NCT00002507 | Completed | Phase 3 | Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer | November 1992 | October 2002 |
NCT00002510 | Completed | Phase 1/Phase 2 | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | April 1992 | June 2001 |
NCT00002514 | Completed | Phase 3 | Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission | May 7, 1993 | |
NCT00002517 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | March 1993 | |
NCT00002519 | Completed | Phase 1 | Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer | January 1997 | January 2000 |
NCT00002521 | Completed | Phase 2 | Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | February 1993 | February 2000 |
NCT00002522 | Completed | Phase 2 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | February 1993 | February 2002 |
NCT00002523 | Completed | Phase 3 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | April 1993 | January 2016 |
NCT00002524 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | June 1993 | October 2005 |
NCT00002528 | Completed | Phase 3 | Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer | May 1993 | August 2010 |
NCT00002533 | Completed | Phase 2/Phase 3 | Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer | February 1993 | August 2006 |
NCT00002536 | Completed | Phase 3 | Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer | December 1996 | |
NCT00002537 | Completed | Phase 1 | Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer | September 1993 | |
NCT00002542 | Completed | Phase 3 | Tamoxifen in Treating Women With High-Risk Breast Cancer | July 20, 1993 | January 11, 2011 |
NCT00002546 | Completed | Phase 3 | Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus | December 1993 | |
NCT00002548 | Completed | Phase 3 | SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma | January 1994 | November 2006 |
NCT00002550 | Completed | Phase 3 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | March 1994 | November 2013 |
NCT00002551 | Completed | Phase 3 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | March 1994 | October 2008 |
NCT00002552 | Completed | Phase 2 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | October 1993 | October 2003 |
NCT00002561 | Completed | Phase 3 | Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease | January 25, 1994 | January 6, 2012 |
NCT00002569 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | July 1994 | May 21, 2018 |
NCT00002571 | Completed | Phase 2 | SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma | June 1994 | July 2011 |
NCT00002577 | Completed | Phase 1/Phase 2 | Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | July 1995 | |
NCT00002579 | Completed | Phase 3 | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | March 1993 | |
NCT00002580 | Completed | Phase 3 | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | June 1993 | |
NCT00002581 | Completed | Phase 3 | Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer | June 1993 | |
NCT00002582 | Completed | Phase 3 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | June 1993 | April 2007 |
NCT00002590 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Lymphoma | July 1994 | March 2007 |
NCT00002596 | Completed | Phase 3 | Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors | September 1994 | July 2006 |
NCT00002597 | Completed | Phase 3 | Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | October 1994 | May 14, 2018 |
NCT00002598 | Completed | Phase 2 | Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | June 1994 | June 2004 |
NCT00002608 | Completed | Phase 2 | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | May 1994 | April 2005 |
NCT00002610 | Completed | Phase 3 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | January 1996 | February 2006 |
NCT00002611 | Completed | Phase 3 | Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | July 1995 | August 2003 |
NCT00002623 | Completed | Phase 3 | Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | December 1994 | |
NCT00002624 | Completed | Phase 2 | Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function | December 1994 | August 2005 |
NCT00002633 | Completed | Phase 3 | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | February 8, 1995 | January 6, 2012 |
NCT00002638 | Completed | Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia | March 1995 | March 2005 |
NCT00002641 | Completed | Phase 3 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | February 1995 | June 2012 |
NCT00002649 | Completed | Phase 3 | Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | May 1995 | |
NCT00002657 | Completed | Phase 2 | SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | May 1995 | July 2011 |
NCT00002665 | Completed | Phase 2 | SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia | July 1995 | December 2003 |
NCT00002679 | Completed | Phase 2 | Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer | February 1994 | January 2002 |
NCT00002680 | Completed | Phase 2 | Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer | February 1994 | December 2000 |
NCT00002689 | Completed | Phase 2 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | September 1995 | June 2007 |
NCT00002697 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | September 1995 | June 2003 |
NCT00002700 | Completed | Phase 3 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | August 1995 | |
NCT00002708 | Completed | Phase 3 | Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases | January 1996 | December 2004 |
NCT00002714 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | April 1995 | September 2001 |
NCT00002718 | Completed | Phase 2 | T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia | November 1995 | October 2008 |
NCT00002727 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord | April 1996 | December 2016 |
NCT00002766 | Completed | Phase 3 | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | March 1996 | September 2011 |
NCT00002788 | Completed | Phase 1 | High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | October 1995 | September 2002 |
NCT00002801 | Completed | Phase 1 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer | April 1996 | December 2009 |
NCT00002807 | Completed | N/A | Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery | July 4, 1996 | December 21, 2009 |
NCT00002809 | Completed | Phase 2 | Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer | August 1996 | December 2003 |
NCT00002812 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia | September 1996 | |
NCT00002822 | Completed | Phase 3 | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | March 1996 | November 2005 |
NCT00002823 | Completed | Phase 3 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | February 1995 | |
NCT00002829 | Completed | Phase 2 | Bone Marrow Transplantation in Treating Patients With Lymphoma | February 1994 | April 2002 |
NCT00002835 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Lymphoma | October 30, 1995 | February 4, 2004 |
NCT00002839 | Completed | Phase 3 | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | July 1996 | |
NCT00002840 | Completed | Phase 3 | Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma | August 1996 | |
NCT00002874 | Completed | Phase 3 | Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy | February 1998 | May 20, 2022 |
NCT00002898 | Completed | Phase 3 | Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma | January 1995 | December 2009 |
NCT00002916 | Completed | Phase 2 | Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer | November 1996 | |
NCT00002932 | Completed | Phase 2 | Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck | May 1997 | March 2005 |
NCT00002945 | Completed | Phase 3 | High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | December 1996 | August 2011 |
NCT00002949 | Completed | Phase 1 | Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | July 1996 | May 2001 |
NCT00002951 | Completed | Phase 2 | Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | June 1996 | July 2006 |
NCT00002982 | Completed | Phase 2 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma | January 1997 | October 2005 |
NCT00002984 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | March 1997 | January 2007 |
NCT00002995 | Completed | Phase 3 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | August 1997 | January 2011 |
NCT00003013 | Completed | Phase 3 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | October 1996 | March 2009 |
NCT00003014 | Completed | Phase 3 | Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer | April 1998 | July 2005 |
NCT00003026 | Completed | Phase 3 | Hormone Therapy in Treating Patients With Advanced Prostate Cancer | April 1997 | |
NCT00003035 | Completed | Phase 2 | Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer | March 1997 | June 2001 |
NCT00003049 | Completed | Phase 3 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | May 1997 | July 2007 |
NCT00003050 | Completed | Phase 2 | Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer | April 1997 | March 2000 |
NCT00003052 | Completed | Phase 3 | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | July 1997 | June 2010 |
NCT00003061 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma | July 1997 | |
NCT00003078 | Completed | Phase 3 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | October 1997 | |
NCT00003081 | Completed | Phase 1 | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma | March 1998 | January 2002 |
NCT00003087 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | August 1997 | February 2005 |
NCT00003089 | Completed | Phase 2 | Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | July 1997 | February 2004 |
NCT00003104 | Completed | Phase 2 | Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer | June 1997 | October 2005 |
NCT00003111 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | April 1997 | April 2004 |
NCT00003114 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease | July 1997 | February 2003 |
NCT00003118 | Completed | Phase 3 | Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | October 1997 | March 2000 |
NCT00003119 | Completed | Phase 3 | Surgery in Treating Children With Neuroblastoma | March 1998 | March 2006 |
NCT00003124 | Completed | Phase 2 | Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer | May 1997 | January 2007 |
NCT00003157 | Completed | Phase 1 | Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach | February 1998 | May 2003 |
NCT00003158 | Completed | Phase 2 | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer | February 1998 | December 2007 |
NCT00003162 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | February 1998 | |
NCT00003187 | Completed | Phase 2/Phase 3 | Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma | May 1995 | February 2005 |
NCT00003193 | Completed | Phase 1/Phase 2 | Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer | January 1998 | September 2005 |
NCT00003195 | Completed | Phase 2 | Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma | December 1997 | November 2000 |
NCT00003199 | Completed | Phase 2 | Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer | November 1997 | December 2009 |
NCT00003200 | Completed | Phase 1 | Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck | October 1995 | June 2008 |
NCT00003202 | Completed | Phase 1/Phase 2 | Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | January 1998 | July 2006 |
NCT00003203 | Completed | Phase 2 | Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors | March 1998 | March 2012 |
NCT00003209 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | December 1997 | |
NCT00003211 | Completed | Phase 2 | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor | October 1996 | June 2007 |
NCT00003215 | Completed | Phase 3 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | April 1997 | March 2004 |
NCT00003216 | Completed | Phase 3 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | July 1998 | |
NCT00003231 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer | April 1997 | September 2000 |
NCT00003235 | Completed | Phase 3 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed | June 1, 1998 | |
NCT00003263 | Completed | Phase 1 | Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | August 1996 | November 2000 |
NCT00003270 | Completed | Phase 2 | Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer | September 4, 1997 | October 16, 2017 |
NCT00003278 | Completed | Phase 2 | Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma | March 1998 | June 2003 |
NCT00003281 | Completed | Phase 2 | Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | April 1998 | March 2006 |
NCT00003290 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Prostate Cancer | January 1998 | August 2004 |
NCT00003298 | Completed | Phase 2 | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | June 1, 1999 | May 2011 |
NCT00003307 | Completed | Phase 2 | Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | March 1998 | June 2001 |
NCT00003309 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer | May 4, 1999 | |
NCT00003313 | Completed | Phase 3 | Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | September 1998 | June 2010 |
NCT00003317 | Completed | Phase 3 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | May 1998 | August 2005 |
NCT00003320 | Completed | N/A | Radiation Therapy Following Surgery to Remove Brain Metastases | March 1997 | |
NCT00003324 | Completed | N/A | Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases | December 1997 | |
NCT00003328 | Completed | Phase 3 | Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | December 1997 | |
NCT00003332 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer | July 1997 | |
NCT00003335 | Completed | Phase 2 | Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer | January 1998 | January 2012 |
NCT00003336 | Completed | Phase 2 | Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions | January 1998 | February 2006 |
NCT00003344 | Completed | Phase 1/Phase 2 | Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer | August 1998 | January 2000 |
NCT00003364 | Completed | Phase 3 | Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | January 1993 | August 2006 |
NCT00084539 | Completed | Phase 2 | Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer | November 2003 | |
NCT00084552 | Completed | N/A | Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer | December 11, 2003 | May 5, 2016 |
NCT00084591 | Completed | Phase 1 | Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | December 2003 | February 2007 |
NCT00084773 | Completed | N/A | Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer | March 2004 | March 2010 |
NCT00084838 | Completed | Phase 2 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | February 2003 | March 2013 |
NCT00085098 | Completed | Phase 3 | Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor | January 2007 | May 2009 |
NCT00085202 | Completed | Phase 3 | Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor | August 2003 | December 31, 2023 |
NCT00085254 | Completed | Phase 1/Phase 2 | Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | April 2005 | November 2012 |
NCT00086931 | Completed | Phase 1/Phase 2 | Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum | September 2003 | May 2010 |
NCT00086996 | Completed | Phase 2 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | September 2004 | August 2011 |
NCT00089024 | Completed | Phase 2 | Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | February 25, 2004 | December 1, 2014 |
NCT00089297 | Completed | Phase 2 | Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer | January 6, 2005 | February 2011 |
NCT00089427 | Completed | Phase 1 | IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma | July 2004 | |
NCT00091039 | Completed | N/A | Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery | August 2004 | February 2006 |
NCT00091052 | Completed | Phase 1/Phase 2 | Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors | July 2004 | June 2006 |
NCT00091351 | Completed | Phase 3 | Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis | August 2004 | February 2006 |
NCT00093509 | Completed | Phase 1/Phase 2 | MRI Sarcoma Non Invasive Thermometry | November 1999 | October 2009 |
NCT00094081 | Completed | Phase 3 | Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer | October 2002 | September 2006 |
NCT00095771 | Completed | Phase 1 | Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas | November 2004 | January 2011 |
NCT00096070 | Completed | Phase 2 | Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer | December 2004 | |
NCT00096135 | Completed | N/A | Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes | November 2004 | |
NCT00096174 | Completed | Phase 2 | Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck | April 8, 2005 | July 2016 |
NCT00096226 | Completed | Phase 2 | Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer | September 2004 | May 16, 2016 |
NCT00096382 | Completed | Phase 2 | Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma | September 2004 | January 2009 |
NCT00098995 | Completed | Phase 1 | Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | December 2004 | January 2010 |
NCT00099125 | Completed | Phase 2 | Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | November 2004 | November 2013 |
NCT00100802 | Completed | Phase 2 | Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas | March 21, 2005 | June 30, 2017 |
NCT00104702 | Completed | Phase 2 | Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer | July 2004 | March 2011 |
NCT00104741 | Completed | Phase 3 | Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer | September 10, 2003 | October 15, 2015 |
NCT00105560 | Completed | N/A | Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma | May 2002 | December 2020 |
NCT00107497 | Completed | N/A | Radiation Therapy in Treating Women With Localized Breast Cancer | October 5, 2004 | March 9, 2017 |
NCT00109837 | Completed | Phase 2 | S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | April 2005 | November 2014 |
NCT00110058 | Completed | Phase 2 | Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia | February 2005 | July 2006 |
NCT00112567 | Completed | Phase 1/Phase 2 | Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | April 2003 | July 2007 |
NCT00112697 | Completed | Phase 2 | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | October 6, 2003 | March 1, 2012 |
NCT00113230 | Completed | Phase 2 | Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer | February 2005 | January 2009 |
NCT00113347 | Completed | Phase 1 | Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | April 2005 | April 2011 |
NCT00114140 | Completed | Phase 2 | Temozolomide and Radiation Therapy in Treating Patients With Gliomas | January 2005 | May 20, 2022 |
NCT00114153 | Completed | Phase 1 | Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | June 2003 | |
NCT00114179 | Completed | Phase 2 | Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | January 2005 | May 2007 |
NCT00114231 | Completed | Phase 2 | Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer | May 2006 | December 2014 |
NCT00117962 | Completed | Phase 2 | Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer | September 2005 | September 2012 |
NCT00119262 | Completed | Phase 2 | Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer | October 2005 | September 2009 |
NCT00119340 | Completed | Phase 1/Phase 2 | Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia | April 2005 | November 2007 |
NCT00124618 | Completed | Phase 2 | Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | January 2006 | March 2015 |
NCT00128700 | Completed | Phase 1/Phase 2 | Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | June 2005 | |
NCT00134004 | Completed | Phase 2 | Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer | October 2004 | January 2015 |
NCT00136474 | Completed | Phase 2 | Amifostine for Head and Neck Irradiation in Lymphoma | May 2003 | March 2009 |
NCT00137852 | Completed | Phase 2 | Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer | January 2002 | September 2017 |
NCT00142480 | Completed | Phase 2 | Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer | December 2004 | April 2011 |
NCT00165126 | Completed | Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma | January 2004 | July 2008 | |
NCT00165490 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer | August 2004 | November 2014 |
NCT00178256 | Completed | Phase 1/Phase 2 | Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer | June 1998 | December 2012 |
NCT00178269 | Completed | Phase 2 | Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix | January 2005 | |
NCT00178295 | Completed | Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury | November 1999 | ||
NCT00182793 | Completed | Phase 2 | Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | July 2005 | October 2014 |
NCT00182819 | Completed | Phase 3 | Radiation Therapy or Temozolomide in Treating Patients With Gliomas | July 2005 | May 2014 |
NCT00183846 | Completed | Phase 1 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | December 2000 | July 2009 |
NCT00187070 | Completed | N/A | Large Cell Lymphoma Pilot Study III | December 1997 | July 2001 |
NCT00187122 | Completed | N/A | Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma | March 1993 | June 2004 |
NCT00187226 | Completed | Phase 2 | A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects | June 1997 | February 1, 2022 |
NCT00187486 | Completed | Phase 2 | Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors | August 2004 | March 2011 |
NCT00191139 | Completed | Phase 2 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | March 2003 | February 2009 |
NCT00193128 | Completed | Phase 1/Phase 2 | Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer | April 2004 | January 2009 |
NCT00193973 | Completed | Phase 2 | Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma | July 2001 | August 2013 |
NCT00206752 | Completed | N/A | Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck | August 2004 | February 2015 |
NCT00225420 | Completed | Phase 1/Phase 2 | Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | August 2005 | August 2012 |
NCT00226239 | Completed | Phase 2 | Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer | October 2005 | July 2013 |
NCT00227630 | Completed | Phase 2 | Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma | July 2005 | |
NCT00227747 | Completed | Phase 3 | Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer | November 8, 2005 | July 15, 2013 |
NCT00231842 | Completed | Phase 2 | Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus | February 2003 | July 2011 |
NCT00233987 | Completed | Phase 2 | S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | October 2005 | December 2017 |
NCT00238147 | Completed | Phase 1 | Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer | September 2004 | August 2008 |
NCT00238251 | Completed | Phase 2 | Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases | May 2005 | November 2010 |
NCT00238264 | Completed | Phase 2 | Radiation Therapy in Treating Young Patients With Gliomas | November 2006 | December 31, 2018 |
NCT00238368 | Completed | Phase 2 | Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant | February 2004 | September 17, 2007 |
NCT00238420 | Completed | Phase 1/Phase 2 | Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer | July 26, 2005 | May 20, 2022 |
NCT00242190 | Completed | Phase 1/Phase 2 | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | June 2004 | February 2010 |
NCT00243048 | Completed | Phase 2 | Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | May 2002 | October 2007 |
NCT00243113 | Completed | Phase 2 | Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx | June 2004 | November 2008 |
NCT00246181 | Completed | Phase 1/Phase 2 | Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC | December 1999 | August 2012 |
NCT00251355 | Completed | Phase 1 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | January 1998 | August 2008 |
NCT00253435 | Completed | Phase 2 | N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma | September 2005 | December 2013 |
NCT00253448 | Completed | Phase 2 | Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme | December 2002 | July 2011 |
NCT00253487 | Completed | N/A | Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas | August 2005 | August 2012 |
NCT00253591 | Completed | Phase 2/Phase 3 | Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | June 2005 | December 2009 |
NCT00255710 | Completed | Phase 1 | Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer | July 2002 | |
NCT00255814 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Liver Metastases | November 2005 | November 2013 |
NCT00258323 | Completed | Phase 2 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | October 2005 | February 2010 |
NCT00258362 | Completed | Phase 2 | Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer | July 2005 | December 2009 |
NCT00258453 | Completed | N/A | Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma | May 2001 | September 2009 |
NCT00262730 | Completed | Phase 2 | Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM | January 2006 | April 2010 |
NCT00264953 | Completed | Phase 3 | HD11 for Intermediate Stages | May 1998 | |
NCT00265031 | Completed | Phase 3 | HD12 for Advanced Stages | January 1999 | |
NCT00265889 | Completed | Phase 2 | Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | February 2002 | April 2010 |
NCT00266097 | Completed | Phase 1 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | August 2004 | September 2011 |
NCT00274755 | Completed | Phase 2 | Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas | November 2003 | |
NCT00274833 | Completed | Phase 2 | Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | October 2005 | September 2012 |
NCT00274937 | Completed | Phase 3 | Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer | February 20, 2006 | September 30, 2022 |
NCT00275015 | Completed | Phase 2 | Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia | January 1998 | April 2012 |
NCT00276640 | Completed | N/A | Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas | April 1, 2004 | May 31, 2017 |
NCT00276809 | Completed | Phase 2 | Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia | June 2001 | September 2004 |
NCT00278148 | Completed | Phase 1/Phase 2 | Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer | October 2005 | February 2011 |
NCT00278304 | Completed | Phase 2 | Radiation Therapy in Treating Patients With Cervical Cancer | September 2005 | June 2006 |
NCT00278408 | Completed | Phase 3 | Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma | November 2005 | February 2018 |
NCT00280176 | Completed | Phase 1 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | April 2003 | September 2010 |
NCT00280761 | Completed | Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy | December 2003 | September 19, 2021 | |
NCT00281788 | Completed | Phase 1 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | September 2003 | July 2007 |
NCT00281840 | Completed | Phase 2 | Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | September 2005 | December 2012 |
NCT00281983 | Completed | Phase 1/Phase 2 | Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia | June 2000 | July 2010 |
NCT00287911 | Completed | Phase 1 | Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer | February 2005 | December 2009 |
NCT00288080 | Completed | Phase 3 | Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer | December 2005 | May 20, 2022 |
NCT00290641 | Completed | N/A | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | April 2001 | January 2006 |
NCT00290667 | Completed | Phase 2 | Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma | February 2004 | November 2015 |
NCT00291707 | Completed | Phase 1 | Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer | March 2006 | January 2009 |
NCT00293358 | Completed | Phase 3 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain | January 1997 | December 2006 |
NCT00296608 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | April 1993 | August 2008 |
NCT00301028 | Completed | Phase 2 | Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer | April 2006 | September 2011 |
NCT00301041 | Completed | Early Phase 1 | Radiation Therapy in Treating Women With Invasive Breast Cancer | April 2004 | May 2004 |
NCT00301808 | Completed | Phase 2 | Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer | November 2005 | October 2012 |
NCT00302003 | Completed | Phase 3 | Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma | February 2006 | June 30, 2019 |
NCT00302159 | Completed | Phase 2 | Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors | March 2006 | November 2014 |
NCT00303810 | Completed | N/A | Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | January 2001 | |
NCT00304083 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors | December 2005 | June 2014 |
NCT00305708 | Completed | Phase 1/Phase 2 | Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission | August 2000 | July 2004 |
NCT00305877 | Completed | Phase 2 | Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery | February 2006 | February 2012 |
NCT00308516 | Completed | Phase 2 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | March 2006 | February 2012 |
NCT00308529 | Completed | Phase 2 | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer | March 2006 | January 2009 |
NCT00310154 | Completed | Phase 1 | Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | November 2003 | August 2010 |
NCT00310167 | Completed | Phase 3 | Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma | October 2005 | January 2017 |
NCT00316862 | Completed | Phase 2 | Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | February 2006 | October 15, 2014 |
NCT00319735 | Completed | Phase 2 | Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas | April 2006 | January 2009 |
NCT00321685 | Completed | Phase 2 | Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer | July 25, 2006 | February 11, 2019 |
NCT00324415 | Completed | Phase 2 | Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | September 2006 | May 2016 |
NCT00328614 | Completed | Phase 1 | Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer | March 2003 | June 2011 |
NCT00328783 | Completed | N/A | Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast Cancer | October 2002 | July 2011 |
NCT00329797 | Completed | Phase 3 | Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy | March 2006 | November 2014 |
NCT00333294 | Completed | Phase 2 | Phase II Iressa + Irradiation Followed by Chemo in NSCLC | September 2004 | January 2006 |
NCT00334997 | Completed | Phase 2 | Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis | September 2005 | July 2006 |
NCT00335543 | Completed | Phase 2 | Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery | June 2003 | October 2009 |
NCT00335556 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors | June 2006 | |
NCT00336648 | Completed | Phase 2 | Preop Chemoradiation Resectable Pancreas | June 2006 | July 2008 |
NCT00336960 | Completed | Phase 2 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | July 2002 | March 2008 |
NCT00354679 | Completed | Phase 2 | Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer | April 2006 | June 2015 |
NCT00354744 | Completed | Phase 3 | High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | July 2006 | June 30, 2019 |
NCT00354835 | Completed | Phase 3 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma | December 26, 2006 | December 31, 2022 |
NCT00356031 | Completed | Phase 2 | Bevacizumab and Radiation Therapy for Sarcomas | July 2006 | March 2010 |
NCT00357253 | Completed | Phase 1 | Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma | January 2006 | March 2010 |
NCT00365287 | Completed | Phase 1/Phase 2 | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer | June 2000 | December 2005 |
NCT00365872 | Completed | Phase 2 | External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma | May 2006 | June 2012 |
NCT00373191 | Completed | Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery | May 2006 | December 2013 | |
NCT00377156 | Completed | Phase 3 | Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | July 2006 | December 15, 2019 |
NCT00379509 | Completed | Phase 1 | Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | April 2006 | August 2012 |
NCT00385853 | Completed | Phase 1 | PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs | September 2006 | September 2011 |
NCT00387374 | Completed | Phase 2 | Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab | October 2006 | |
NCT00387699 | Completed | Phase 2 | Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | October 2006 | April 2014 |
NCT00389584 | Completed | Phase 1/Phase 2 | Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors | December 2002 | November 2006 |
NCT00390403 | Completed | Phase 1 | Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | February 2007 | |
NCT00392704 | Completed | Phase 2 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | December 2006 | May 2012 |
NCT00393068 | Completed | Phase 2 | Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer | February 2007 | August 2011 |
NCT00398554 | Completed | Phase 2 | Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma | June 2005 | March 2013 |
NCT00400946 | Completed | Phase 3 | Treatment of Acute Lymphoblastic Leukemia in Children | April 2005 | June 2019 |
NCT00402116 | Completed | Phase 1/Phase 2 | Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients | September 2006 | December 2009 |
NCT00403065 | Completed | Phase 3 | Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery | October 2006 | March 2013 |
NCT00408564 | Completed | Phase 2 | Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | January 2006 | April 2013 |
NCT00416832 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | November 2002 | December 2005 |
NCT00416858 | Completed | Phase 3 | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | April 2007 | |
NCT00423475 | Completed | Phase 3 | Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer | October 2006 | |
NCT00430118 | Completed | Phase 3 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | July 2000 | January 2012 |
NCT00433459 | Completed | Phase 3 | Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma | January 2007 | January 2013 |
NCT00436397 | Completed | N/A | A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer | June 2002 | August 2005 |
NCT00441142 | Completed | Phase 1/Phase 2 | Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors | May 25, 2007 | October 10, 2017 |
NCT00442455 | Completed | Phase 3 | Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck | January 2006 | August 2015 |
NCT00449020 | Completed | Phase 2 | Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer | January 2004 | January 2008 |
NCT00450736 | Completed | Phase 1 | Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | March 2004 | May 2009 |
NCT00458848 | Completed | Phase 2 | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia | October 2004 | March 2014 |
NCT00460174 | Completed | Phase 2 | Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer | October 10, 2005 | July 16, 2010 |
NCT00462501 | Completed | N/A | Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer | March 2007 | February 2014 |
NCT00467116 | Completed | Phase 1 | PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca | October 2005 | October 2007 |
NCT00470184 | Completed | Phase 2 | Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | November 2006 | |
NCT00482014 | Completed | Phase 1/Phase 2 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer | May 2007 | October 2011 |
NCT00498953 | Completed | Phase 1/Phase 2 | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx | May 2007 | March 2009 |
NCT00499083 | Completed | Phase 2 | Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) | May 1, 2006 | January 28, 2010 |
NCT00499447 | Completed | N/A | Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | May 2007 | March 2010 |
NCT00502411 | Completed | Phase 1 | Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma | January 2003 | April 2015 |
NCT00521183 | Completed | Phase 1 | Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain | June 2007 | May 2014 |
NCT00524121 | Completed | Phase 2 | Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer | March 2006 | October 2011 |
NCT00525915 | Completed | Phase 2 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | April 2005 | March 2013 |
NCT00528866 | Completed | Phase 2 | Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy | April 2008 | May 14, 2018 |
NCT00529100 | Completed | Phase 1/Phase 2 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer | December 2005 | September 2012 |
NCT00535795 | Completed | Phase 3 | Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA | September 2007 | September 2015 |
NCT00541047 | Completed | Phase 3 | RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery | November 2007 | July 27, 2022 |
NCT00543842 | Completed | Phase 1 | Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer | December 2007 | December 2013 |
NCT00544193 | Completed | Phase 1 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | December 1997 | August 2012 |
NCT00544570 | Completed | N/A | High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma | April 1998 | December 2007 |
NCT00544817 | Completed | Phase 2 | Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme | April 2007 | August 2010 |
NCT00553462 | Completed | Phase 2 | Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | March 2008 | June 15, 2017 |
NCT00554463 | Completed | Phase 2 | G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer | January 2008 | August 3, 2011 |
NCT00556621 | Completed | Phase 1/Phase 2 | Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer | June 2005 | August 2009 |
NCT00559156 | Completed | Phase 2 | Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy | June 2005 | |
NCT00562718 | Completed | Phase 2 | Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery | September 2004 | November 2009 |
NCT00563784 | Completed | Phase 2 | TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | November 2007 | May 30, 2018 |
NCT00581971 | Completed | Phase 1/Phase 2 | Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer | September 2002 | March 2012 |
NCT00589056 | Completed | Phase 1/Phase 2 | Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | June 2007 | March 2012 |
NCT00589121 | Completed | Phase 2 | Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg | March 2008 | May 21, 2018 |
NCT00589875 | Completed | Phase 2 | Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma | March 2007 | August 2016 |
NCT00601627 | Completed | Phase 2 | Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery | June 2009 | May 2013 |
NCT00601692 | Completed | Phase 1 | Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer | April 2003 | December 2009 |
NCT00602602 | Completed | Phase 2 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | March 2007 | September 2011 |
NCT00602628 | Completed | N/A | Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast | November 2007 | January 2009 |
NCT00608205 | Completed | Phase 3 | Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer | January 2008 | August 2016 |
NCT00613080 | Completed | Phase 2 | Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | April 2008 | December 2016 |
NCT00614653 | Completed | Phase 1 | Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer | January 2008 | July 2016 |
NCT00618813 | Completed | N/A | Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors | March 2008 | |
NCT00629863 | Completed | N/A | Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer | September 2004 | January 2010 |
NCT00634725 | Completed | Phase 3 | Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery | February 2008 | September 2014 |
NCT00639366 | Completed | Phase 3 | Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer | February 2007 | October 2010 |
NCT00647582 | Completed | Phase 2 | Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer | October 2002 | December 21, 2013 |
NCT00650923 | Completed | Phase 1 | Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma | July 2008 | December 2013 |
NCT00655876 | Completed | Phase 3 | Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer | June 2008 | May 20, 2022 |
NCT00660270 | Completed | Phase 2 | Chemotherapy and Radiation Following Pancreatic Surgery | May 2002 | February 2009 |
NCT00662233 | Completed | Early Phase 1 | Combination Chemotherapy in Treating Patients With Sarcoma | October 1991 | October 21, 2013 |
NCT00666484 | Completed | Phase 2 | Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma | March 2008 | September 2012 |
NCT00669162 | Completed | Phase 1/Phase 2 | Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer | August 2012 | April 2017 |
NCT00671034 | Completed | Phase 3 | Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia | July 21, 2008 | March 31, 2021 |
NCT00686166 | Completed | Phase 2 | S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer | February 2009 | March 2018 |
NCT00701857 | Completed | Phase 1 | Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer | February 2008 | September 2015 |
NCT00703976 | Completed | Phase 2 | Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer | October 2008 | September 2014 |
NCT00707278 | Completed | Phase 1 | Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma | September 2005 | August 2011 |
NCT00720109 | Completed | Phase 2/Phase 3 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | July 14, 2008 | March 31, 2020 |
NCT00720304 | Completed | Phase 2 | Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck | November 2007 | November 2015 |
NCT00720564 | Completed | Phase 1 | Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma | April 2008 | February 2009 |
NCT00727584 | Completed | N/A | Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression | November 2007 | August 2009 |
NCT00727831 | Completed | Phase 1/Phase 2 | Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | July 2008 | July 2011 |
NCT00732563 | Completed | N/A | Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery | July 16, 2008 | July 26, 2017 |
NCT00735306 | Completed | Phase 1 | Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma | July 2008 | October 2011 |
NCT00738452 | Completed | Phase 1 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy | August 6, 2008 | February 7, 2018 |
NCT00751816 | Completed | Head & Neck Cancer Survivorship: Physical and Functional Status | June 2008 | January 2009 | |
NCT00757172 | Completed | Phase 2 | Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction | January 2009 | December 2014 |
NCT00757549 | Completed | Early Phase 1 | 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx | September 2008 | October 25, 2017 |
NCT00770471 | Completed | Phase 1 | ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | July 13, 2009 | March 1, 2012 |
NCT00771641 | Completed | Phase 3 | Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck | November 2013 | |
NCT00796796 | Completed | Phase 1 | Temsirolimus and Radiation for Non-Small Cell Lung Cancer | March 2009 | July 2011 |
NCT00798655 | Completed | Phase 2 | Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer | November 2007 | November 9, 2016 |
NCT00805961 | Completed | Phase 2 | RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM | January 2009 | May 2013 |
NCT00820963 | Completed | Phase 3 | Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme | July 2006 | |
NCT00836186 | Completed | N/A | Cytokine Expression During Radiation for Breast Cancer | November 13, 2009 | November 1, 2019 |
NCT00838929 | Completed | Phase 1 | Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases | March 2009 | March 2015 |
NCT00849082 | Completed | Phase 3 | Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | May 1987 | |
NCT00861094 | Completed | Phase 2/Phase 3 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | March 2008 | December 2012 |
NCT00867347 | Completed | Phase 3 | Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer | July 2007 | April 2017 |
NCT00869401 | Completed | Phase 1/Phase 2 | Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | June 2009 | November 15, 2019 |
NCT00869570 | Completed | Phase 1/Phase 2 | External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer | March 2009 | September 2016 |
NCT00871923 | Completed | Phase 2 | Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer | March 26, 2009 | December 4, 2019 |
NCT00872625 | Completed | Phase 1 | Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | April 2007 | December 2010 |
NCT00875849 | Completed | Phase 2 | Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer | March 2008 | December 2013 |
NCT00879437 | Completed | Phase 2 | Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma | September 1, 2009 | October 2, 2017 |
NCT00884598 | Completed | Phase 1 | Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer | December 2008 | October 2012 |
NCT00897793 | Completed | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | January 2006 | July 2010 | |
NCT00898352 | Completed | Phase 3 | Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph Nodes | ||
NCT00916578 | Completed | Phase 2 | Xeloda (Capecitabine) and External Beam Radiation | June 5, 2009 | June 6, 2017 |
NCT00929591 | Completed | Phase 3 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | May 1989 | March 2010 |
NCT00938470 | Completed | Phase 2 | Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | January 2010 | March 2018 |
NCT00943826 | Completed | Phase 3 | A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma | June 29, 2009 | September 9, 2015 |
NCT00946673 | Completed | Phase 1 | Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer | June 2009 | July 2015 |
NCT00960492 | Completed | Phase 1 | Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma | September 2009 | October 2013 |
NCT00964977 | Completed | Phase 3 | Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis. | October 2009 | December 2021 |
NCT00968643 | Completed | Phase 3 | Spinal Cord Compression. ICORG 05-03, V6 | January 2006 | |
NCT00972881 | Completed | Phase 1/Phase 2 | Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | April 2009 | December 31, 2016 |
NCT00978549 | Completed | Phase 3 | Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | April 2008 | October 2010 |
NCT00983359 | Completed | N/A | Stereotactic Radiation Therapy in Treating Patients With Brain Metastases | April 2007 | August 2012 |
NCT01055197 | Completed | Phase 2 | Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer | March 2010 | December 2016 |
NCT01062399 | Completed | Phase 1/Phase 2 | Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | December 2010 | May 20, 2022 |
NCT01064921 | Completed | Phase 1 | Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma | January 19, 2010 | November 8, 2017 |
NCT01102088 | Completed | Phase 1 | Simultaneous Integrated Boost (SIB) in Esophageal Cancer | April 2010 | June 8, 2019 |
NCT01117441 | Completed | Phase 3 | International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia | June 2010 | December 31, 2021 |
NCT01118026 | Completed | Phase 2 | Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma | September 2010 | September 29, 2021 |
NCT01118377 | Completed | Phase 2 | A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas | May 2007 | April 2013 |
NCT01132807 | Completed | Phase 2 | Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | May 2010 | January 2018 |
NCT01134861 | Completed | Phase 3 | Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | July 1994 | March 2012 |
NCT01142102 | Completed | N/A | Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer | October 2010 | June 2015 |
NCT01186978 | Completed | N/A | Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma | September 20, 2010 | June 4, 2019 |
NCT01196390 | Completed | Phase 3 | Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer | February 14, 2011 | August 15, 2023 |
NCT01222221 | Completed | Phase 1 | Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | July 2010 | February 2015 |
NCT01227707 | Completed | Phase 2 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | November 2005 | August 2010 |
NCT01230983 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma | June 1996 | October 2004 |
NCT01233843 | Completed | Phase 3 | Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. | May 18, 2009 | November 6, 2018 |
NCT01242800 | Completed | N/A | Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer | May 16, 2011 | December 21, 2022 |
NCT01263171 | Completed | Phase 2 | Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery | April 2012 | November 2015 |
NCT01264432 | Completed | Phase 1 | Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer | January 1, 2011 | November 15, 2016 |
NCT01269424 | Completed | Phase 1 | BG & TMZ Therapy of Glioblastoma Multiforme | November 22, 2011 | September 26, 2022 |
NCT01288534 | Completed | Phase 2 | Hypofractionated Stereotactic Body Radiation Therapy (SBRT) | January 2011 | January 2016 |
NCT01333033 | Completed | Phase 2 | PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy | July 2011 | April 1, 2023 |
NCT01345370 | Completed | Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients | March 2009 | June 2015 | |
NCT01384799 | Completed | Phase 1 | Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer | November 2011 | October 2013 |
NCT01401062 | Completed | Phase 2 | Fresolimumab and Radiotherapy in Metastatic Breast Cancer | July 2011 | June 2014 |
NCT01443676 | Completed | Phase 2 | Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma | October 2011 | August 2016 |
NCT01445405 | Completed | Phase 1 | Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer | February 5, 2008 | August 27, 2010 |
NCT01449279 | Completed | Phase 2 | Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy | October 2011 | December 1, 2016 |
NCT01459497 | Completed | Phase 3 | Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer | October 2012 | October 19, 2023 |
NCT01469247 | Completed | Phase 1/Phase 2 | Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) | December 7, 2011 | September 20, 2022 |
NCT01481545 | Completed | Phase 2 | Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | December 2006 | December 2016 |
NCT01486602 | Completed | Phase 1 | Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | March 2012 | January 16, 2018 |
NCT01496131 | Completed | Phase 2 | Tecemotide (L-BLP25) in Prostate Cancer | October 24, 2011 | November 25, 2016 |
NCT01526603 | Completed | N/A | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | March 28, 2012 | May 30, 2023 |
NCT01534637 | Completed | Phase 2 | Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer | August 2006 | August 2012 |
NCT01540994 | Completed | Phase 1/Phase 2 | Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | January 2011 | April 5, 2019 |
NCT01560949 | Completed | Phase 2 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | June 14, 2012 | February 20, 2019 |
NCT01561014 | Completed | Phase 1 | Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | April 2007 | March 2009 |
NCT01591135 | Completed | Phase 3 | A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma | April 2012 | August 2018 |
NCT01666808 | Completed | Phase 2/Phase 3 | FACBC Outcomes for Post Prostatectomy | September 2012 | April 18, 2022 |
NCT01674842 | Completed | Phase 1 | Cisplatin + RT for Triple Negative Breast Cancer | October 2012 | June 8, 2021 |
NCT01711541 | Completed | Phase 1/Phase 2 | Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer | October 22, 2012 | May 15, 2023 |
NCT01717053 | Completed | Phase 2 | Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | January 17, 2014 | August 31, 2021 |
NCT01730950 | Completed | Phase 2 | Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma | December 20, 2012 | December 22, 2022 |
NCT01740258 | Completed | Phase 2 | Bevacizumab Beyond Progression (BBP) | January 2013 | November 14, 2019 |
NCT01740648 | Completed | Phase 1 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | November 26, 2012 | September 29, 2021 |
NCT01758731 | Completed | Phase 1 | Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History | October 22, 2012 | October 31, 2018 |
NCT01783587 | Completed | Phase 1 | Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer | February 2013 | June 1, 2018 |
NCT01790503 | Completed | Phase 1/Phase 2 | A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma | July 18, 2013 | March 4, 2020 |
NCT01819233 | Completed | N/A | Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy | March 8, 2013 | September 2019 |
NCT01831531 | Completed | Phase 2 | Study of S-1 in Combination With Radiotherapy in Esophageal Cancer | March 2013 | October 2018 |
NCT01833208 | Completed | N/A | Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T | July 3, 2013 | January 23, 2021 |
NCT01835626 | Completed | Phase 2 | Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma | May 2013 | September 10, 2019 |
NCT01869192 | Completed | Phase 2 | Phase II Trial for Large ER-Negative Breast Cancers | March 5, 2003 | August 21, 2010 |
NCT01893294 | Completed | Phase 1 | Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer | April 2013 | October 30, 2015 |
NCT01903018 | Completed | Phase 2 | A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 | July 2012 | September 2014 |
NCT01922076 | Completed | Phase 1 | Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas | September 3, 2013 | September 30, 2022 |
NCT01958372 | Completed | Phase 1 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | August 2014 | November 11, 2019 |
NCT01977677 | Completed | Phase 1/Phase 2 | Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma | November 2014 | September 2018 |
NCT01979211 | Completed | Phase 2 | Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck | October 2013 | January 19, 2022 |
NCT01985958 | Completed | N/A | A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas | July 2013 | December 2019 |
NCT02037230 | Completed | Phase 1/Phase 2 | Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas | January 2014 | August 2018 |
NCT02046304 | Completed | Phase 1 | PP-Gemcitabine & External Beam Radiation-Sarcomas | December 2001 | March 2015 |
NCT02057939 | Completed | Phase 2 | Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) | April 2014 | June 5, 2019 |
NCT02104193 | Completed | Phase 2 | Simvastatin Effect on Radiation Therapy of Brain Metastases | April 2014 | December 2015 |
NCT02122081 | Completed | Phase 1 | Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies | July 27, 2015 | September 6, 2022 |
NCT02180698 | Completed | Phase 1 | TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery | November 17, 2014 | October 7, 2016 |
NCT02184533 | Completed | Phase 1 | Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer | July 2014 | May 2018 |
NCT02203565 | Completed | Phase 2 | Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy | July 2014 | July 7, 2016 |
NCT02241499 | Completed | Phase 2 | Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. | October 2014 | May 2019 |
NCT02243358 | Completed | Phase 2 | Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer | February 2014 | January 14, 2020 |
NCT02254772 | Completed | Phase 1/Phase 2 | A Phase I/II Study of Intratumoral Injection of SD-101 | September 2014 | January 26, 2017 |
NCT02274350 | Completed | The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects | May 2015 | November 2015 | |
NCT02280252 | Completed | Phase 2 | Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response | March 2005 | December 20, 2018 |
NCT02318095 | Completed | N/A | Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer | February 17, 2015 | November 14, 2022 |
NCT02325401 | Completed | Phase 1 | Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | May 11, 2015 | February 21, 2020 |
NCT02337426 | Completed | Phase 1 | Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | February 13, 2015 | November 9, 2017 |
NCT02379845 | Completed | Phase 2/Phase 3 | NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall | March 3, 2015 | September 20, 2020 |
NCT02389751 | Completed | Phase 1 | Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer | April 10, 2015 | July 16, 2019 |
NCT02394535 | Completed | Phase 1 | Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer | November 12, 2015 | August 31, 2022 |
NCT02397486 | Completed | Phase 2 | The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients | May 2, 2015 | June 30, 2018 |
NCT02459652 | Completed | Phase 2 | Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer | December 28, 2012 | July 17, 2018 |
NCT02472275 | Completed | Phase 1 | PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer | June 2015 | August 5, 2019 |
NCT02474186 | Completed | Phase 2 | Phase II Study for Solid Metastatic Tumors | April 2003 | July 2015 |
NCT02501954 | Completed | Phase 3 | Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol | March 2015 | November 2023 |
NCT02528942 | Completed | N/A | Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients | April 22, 2016 | January 25, 2021 |
NCT02730546 | Completed | Phase 1/Phase 2 | Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery | June 24, 2016 | October 31, 2023 |
NCT02759575 | Completed | Phase 1/Phase 2 | A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma | April 2016 | February 2021 |
NCT02769299 | Completed | Cardiotoxicity of Radiation Therapy (CTRT) | June 2, 2015 | November 26, 2018 | |
NCT02773238 | Completed | Phase 2 | FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging | May 20, 2016 | December 1, 2023 |
NCT02805530 | Completed | N/A | Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma | June 2015 | January 2019 |
NCT02911350 | Completed | Phase 1 | Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer | May 2000 | December 2016 |
NCT02927964 | Completed | Phase 1/Phase 2 | TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma | November 7, 2016 | May 18, 2023 |
NCT02958787 | Completed | Phase 2 | Vessel Sparing Prostate Radiation Therapy | November 2004 | October 2009 |
NCT02970617 | Completed | N/A | Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients | August 15, 2016 | November 15, 2018 |
NCT02990468 | Completed | Phase 1/Phase 2 | A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer | April 19, 2017 | March 31, 2022 |
NCT03095209 | Completed | Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery | February 24, 2017 | January 18, 2021 | |
NCT03109080 | Completed | Phase 1 | Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC) | July 24, 2017 | November 29, 2021 |
NCT03151642 | Completed | A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION | April 5, 2017 | April 23, 2021 | |
NCT03165994 | Completed | Phase 2 | APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers | October 6, 2017 | February 21, 2023 |
NCT03224104 | Completed | Phase 1 | Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma | June 12, 2018 | May 5, 2022 |
NCT03267888 | Completed | Phase 1 | Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma | May 29, 2018 | September 2, 2022 |
NCT03281811 | Completed | Early Phase 1 | Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides | November 13, 2017 | August 12, 2020 |
NCT03297710 | Completed | Phase 1 | TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery | December 11, 2017 | April 30, 2021 |
NCT03320421 | Completed | N/A | Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery | January 1, 2017 | January 1, 2019 |
NCT03324802 | Completed | Phase 3 | Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery | February 7, 2018 | August 28, 2023 |
NCT03335540 | Completed | Phase 1 | An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment | May 7, 2018 | August 25, 2021 |
NCT03338959 | Completed | Phase 1/Phase 2 | Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma | March 28, 2018 | August 4, 2023 |
NCT03438318 | Completed | Phase 1 | Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer | March 15, 2018 | December 11, 2019 |
NCT03477110 | Completed | Early Phase 1 | Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma | May 4, 2018 | January 26, 2024 |
NCT03515538 | Completed | Phase 2 | Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers | July 12, 2018 | October 8, 2020 |
NCT03523351 | Completed | Phase 1/Phase 2 | Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain | May 1, 2018 | April 18, 2024 |
NCT03524170 | Completed | Phase 1 | Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer | April 30, 2018 | February 10, 2022 |
NCT03617913 | Completed | Phase 2 | Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer | September 19, 2018 | July 27, 2020 |
NCT03677531 | Completed | Phase 1 | Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation Therapy | May 31, 2018 | September 25, 2019 |
NCT03691493 | Completed | Phase 2 | Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis | February 8, 2019 | October 13, 2022 |
NCT03696355 | Completed | Phase 1 | Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas | November 19, 2018 | September 4, 2022 |
NCT03798639 | Completed | Phase 1 | Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer | January 7, 2019 | December 2, 2022 |
NCT03824366 | Completed | N/A | Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy | April 23, 2019 | January 14, 2022 |
NCT04050085 | Completed | Phase 1 | SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer | August 15, 2019 | May 14, 2022 |
NCT04091867 | Completed | Phase 1 | sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC | January 6, 2020 | October 25, 2022 |
NCT04451603 | Completed | LiverMultiScan Analysis of MRI Scans in HCC | October 19, 2018 | December 31, 2023 | |
NCT04465162 | Completed | Phase 2 | Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma | June 7, 2000 | March 15, 2021 |
NCT04541355 | Completed | Phase 2 | Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin | October 14, 2020 | July 31, 2023 |
NCT04636762 | Completed | Phase 2 | A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | June 1, 2020 | May 1, 2022 |
NCT04782726 | Completed | N/A | Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution | December 16, 2021 | January 20, 2023 |
NCT01968538 | Enrolling by invitation | Metabolomic Study for Localized Prostate Cancer | January 2009 | December 2024 | |
NCT06310369 | Not yet recruiting | Phase 2 | Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer | March 1, 2025 | March 1, 2030 |
NCT04176081 | Not yet recruiting | Phase 2 | Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer | July 2, 2024 | December 2028 |
NCT06025747 | Not yet recruiting | Phase 1 | Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma | July 1, 2024 | March 3, 2026 |
NCT06305715 | Not yet recruiting | Phase 2 | Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X) | July 15, 2024 | June 15, 2028 |
NCT05962242 | Not yet recruiting | Phase 2 | HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma | January 1, 2024 | November 1, 2029 |
NCT06236997 | Not yet recruiting | Phase 2 | Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer | February 10, 2024 | December 31, 2027 |
NCT06434350 | Not yet recruiting | Phase 1/Phase 2 | Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE) | November 29, 2024 | September 24, 2027 |
NCT06124157 | Not yet recruiting | Phase 3 | A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL) | July 22, 2024 | December 1, 2030 |
NCT05296005 | Not yet recruiting | Phase 1 | Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers | May 31, 2022 | December 31, 2024 |
NCT04157478 | Not yet recruiting | Phase 2 | Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma | January 2020 | December 2024 |
NCT03541486 | Not yet recruiting | Phase 2 | A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients | December 31, 2025 | December 31, 2030 |
NCT05986318 | Not yet recruiting | Phase 2 | Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease | May 1, 2024 | December 31, 2032 |
NCT06099951 | Not yet recruiting | Phase 2 | Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy | November 1, 2023 | September 1, 2027 |
NCT05608369 | Not yet recruiting | Phase 2 | Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC | June 1, 2024 | February 1, 2026 |
NCT06448286 | Not yet recruiting | Phase 3 | PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma | June 1, 2024 | June 1, 2027 |
NCT06330545 | Not yet recruiting | N/A | Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release | April 2024 | April 2032 |
NCT06344130 | Not yet recruiting | Phase 1 | Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma | June 23, 2024 | December 31, 2027 |
NCT05721755 | Recruiting | Phase 3 | Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck | June 8, 2023 | March 31, 2030 |
NCT05190172 | Recruiting | N/A | PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas | January 14, 2022 | December 31, 2041 |
NCT03919071 | Recruiting | Phase 2 | Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma | February 20, 2020 | September 30, 2027 |
NCT02098252 | Recruiting | N/A | Treatment of Brain AVMs (TOBAS) Study | May 2014 | January 2036 |
NCT04567771 | Recruiting | N/A | Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer | December 4, 2020 | October 15, 2024 |
NCT02927912 | Recruiting | Phase 2 | Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction | October 16, 2017 | December 31, 2024 |
NCT02106988 | Recruiting | Phase 2 | Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma | January 16, 2015 | January 31, 2034 |
NCT02912312 | Recruiting | Phase 2 | Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer | February 23, 2017 | February 28, 2031 |
NCT03914625 | Recruiting | Phase 3 | A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia | July 3, 2019 | June 30, 2029 |
NCT02905591 | Recruiting | Phase 2 | A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC | November 16, 2018 | December 31, 2027 |
NCT05704985 | Recruiting | Phase 1 | Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors | April 3, 2023 | February 2025 |
NCT05198830 | Recruiting | Phase 2 | Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer | December 15, 2022 | December 31, 2025 |
NCT05607017 | Recruiting | Early Phase 1 | Losartan in Prevention of Radiation-Induced Heart Failure | January 1, 2024 | December 1, 2024 |
NCT05568550 | Recruiting | Phase 2 | Pembro With Radiation With or Without Olaparib | July 27, 2023 | July 2, 2029 |
NCT05560009 | Recruiting | An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas | November 10, 2022 | July 1, 2025 | |
NCT05236036 | Recruiting | Phase 1 | Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma | August 8, 2022 | January 3, 2027 |
NCT05513443 | Recruiting | N/A | Prostate Cancer IRE Study (PRIS) | September 1, 2022 | September 1, 2025 |
NCT05245682 | Recruiting | Early Phase 1 | Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer | February 17, 2022 | October 21, 2025 |
NCT05268614 | Recruiting | Phase 2 | Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma | May 16, 2022 | June 2032 |
NCT04248452 | Recruiting | Phase 3 | Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body | May 26, 2020 | March 31, 2028 |
NCT05294120 | Recruiting | Phase 2 | A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma | March 3, 2022 | March 2025 |
NCT04402788 | Recruiting | Phase 2/Phase 3 | Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial | January 7, 2021 | April 30, 2027 |
NCT03875716 | Recruiting | N/A | Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma | May 20, 2019 | December 31, 2027 |
NCT03858205 | Recruiting | N/A | Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma | March 11, 2019 | March 11, 2026 |
NCT05304585 | Recruiting | Phase 3 | Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma | August 4, 2022 | December 31, 2030 |
NCT05491226 | Recruiting | Phase 2 | Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation | November 17, 2023 | December 1, 2025 |
NCT02287428 | Recruiting | Phase 1 | Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM | November 2014 | June 2026 |
NCT05336383 | Recruiting | Phase 2 | Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma | May 31, 2022 | December 7, 2024 |
NCT04588545 | Recruiting | Phase 1/Phase 2 | Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease | December 10, 2020 | November 1, 2024 |
NCT03801902 | Recruiting | Phase 1 | Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), The ARCHON-1 Trial | October 28, 2019 | March 31, 2025 |
NCT05387915 | Recruiting | Phase 2 | Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer | June 6, 2022 | May 5, 2026 |
NCT02344121 | Recruiting | Intra- and Inter-fraction Changes in Radiation Therapy | January 2015 | January 1, 2030 | |
NCT04594187 | Recruiting | Phase 2 | Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma | August 26, 2021 | February 24, 2025 |
NCT02468024 | Recruiting | Phase 3 | JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer | July 2015 | December 2024 |
NCT05488366 | Recruiting | Early Phase 1 | Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma | August 3, 2022 | August 2024 |
NCT04266249 | Recruiting | Phase 2 | CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy | March 13, 2020 | December 31, 2038 |
NCT05443971 | Recruiting | Phase 2 | Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen | July 3, 2023 | June 30, 2025 |
NCT05417386 | Recruiting | Phase 1 | FOLFIRINOX + NIS793 in Pancreatic Cancer | August 9, 2022 | May 1, 2025 |
NCT05406232 | Recruiting | Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer | September 15, 2023 | December 31, 2026 | |
NCT05411094 | Recruiting | Phase 1 | Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer | May 22, 2023 | March 31, 2025 |
NCT04594772 | Recruiting | Phase 2 | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | March 17, 2021 | January 1, 2026 |
NCT06295744 | Recruiting | N/A | Outcomes and Cosmesis With Whole Breast Irradiation and Boost | April 17, 2024 | February 2032 |
NCT03746080 | Recruiting | Phase 2 | Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma | December 4, 2018 | July 2027 |
NCT03739411 | Recruiting | Phase 1 | Hyperpolarized Imaging in Diagnosing Participants With Glioma | December 9, 2015 | June 30, 2024 |
NCT04614909 | Recruiting | Early Phase 1 | Study of Pamiparib in Newly Diagnosed and rGBM | January 11, 2021 | December 2024 |
NCT04097067 | Recruiting | N/A | ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma | September 1, 2019 | August 31, 2025 |
NCT04616248 | Recruiting | Phase 1 | In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors | January 9, 2023 | January 9, 2026 |
NCT04175431 | Recruiting | Phase 2 | Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study | September 30, 2020 | July 1, 2029 |
NCT04427566 | Recruiting | Phase 2 | Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise | July 23, 2020 | December 31, 2021 |
NCT06244004 | Recruiting | Phase 2 | FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial | February 18, 2024 | February 18, 2028 |
NCT04623931 | Recruiting | Phase 2 | Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas | January 30, 2020 | December 31, 2026 |
NCT04428671 | Recruiting | Phase 1 | Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer | May 15, 2020 | October 1, 2030 |
NCT04430699 | Recruiting | Phase 2 | Cisplatin+Pembrolizumab+RT in Vulvar Cancer | July 29, 2020 | January 30, 2028 |
NCT04643366 | Recruiting | Phase 2 | Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer | January 28, 2021 | January 31, 2033 |
NCT04322318 | Recruiting | Phase 2 | A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT | October 19, 2020 | July 1, 2027 |
NCT04658537 | Recruiting | N/A | Advanced Techniques for Single-fraction Palliative Radiotherapy Versus ASPIRE-single | June 29, 2021 | December 31, 2024 |
NCT03687957 | Recruiting | Phase 1/Phase 2 | rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide | January 4, 2019 | January 31, 2032 |
NCT03678025 | Recruiting | Phase 3 | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | September 24, 2018 | October 1, 2031 |
NCT04075305 | Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | February 1, 2019 | May 1, 2025 | |
NCT04359199 | Recruiting | QUantitative Assessment of Swallowing After Radiation (QUASAR) | September 1, 2020 | December 31, 2024 | |
NCT06208826 | Recruiting | Phase 2 | A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy | September 1, 2023 | September 1, 2028 |
NCT04375891 | Recruiting | N/A | Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation | May 22, 2020 | May 2026 |
NCT04684368 | Recruiting | Phase 2 | A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT | July 13, 2021 | December 21, 2029 |
NCT04728230 | Recruiting | Phase 1/Phase 2 | Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial | January 5, 2021 | December 31, 2025 |
NCT04745390 | Recruiting | N/A | Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer | August 1, 2021 | April 2027 |
NCT06177925 | Recruiting | Phase 2 | A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC | December 10, 2023 | September 30, 2026 |
NCT03598257 | Recruiting | Phase 2 | Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer | January 18, 2019 | June 1, 2027 |
NCT01473628 | Recruiting | Phase 1/Phase 2 | Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma | May 20, 2013 | May 20, 2027 |
NCT04759586 | Recruiting | Phase 3 | Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma | October 5, 2021 | September 30, 2027 |
NCT04837209 | Recruiting | Phase 2 | Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer | July 21, 2021 | December 1, 2029 |
NCT05099003 | Recruiting | Phase 1/Phase 2 | A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) | May 31, 2022 | June 30, 2027 |
NCT05100095 | Recruiting | Phase 2 | Hypofractionated Radiation Therapy for Merkel Cell Carcinoma | December 14, 2021 | September 1, 2028 |
NCT03161522 | Recruiting | Phase 2 | Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer | February 19, 2018 | December 31, 2026 |
NCT05982691 | Recruiting | Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors | August 5, 2022 | December 31, 2032 | |
NCT01973179 | Recruiting | Re-irradiation of Recurrent Head and Neck Cancer | July 2015 | December 2026 | |
NCT04545957 | Recruiting | N/A | Jump: MR Simulation For Radiation Therapy Master Protocol | October 14, 2020 | October 22, 2026 |
NCT03107780 | Recruiting | Phase 1 | Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer | July 9, 2018 | December 31, 2024 |
NCT03104439 | Recruiting | Phase 2 | Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer | May 10, 2017 | October 2026 |
NCT05124912 | Recruiting | N/A | REMASTer: REcurrent Brain Metastases After SRS Trial | May 10, 2022 | October 2028 |
NCT05879653 | Recruiting | Phase 2 | Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD) | October 1, 2023 | September 30, 2027 |
NCT05879250 | Recruiting | Phase 2 | WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | May 22, 2024 | December 27, 2028 |
NCT05136846 | Recruiting | Phase 1 | Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer | December 6, 2021 | December 31, 2025 |
NCT05838599 | Recruiting | Early Phase 1 | Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides | July 24, 2023 | February 1, 2026 |
NCT02970448 | Recruiting | Early Phase 1 | Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas | August 24, 2017 | June 1, 2024 |
NCT05781321 | Recruiting | Phase 2 | Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study | March 23, 2023 | March 2, 2028 |
NCT04555577 | Recruiting | Phase 1 | Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma | September 20, 2020 | October 30, 2025 |
NCT04134260 | Recruiting | Phase 3 | Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer | March 5, 2020 | November 1, 2026 |
NCT05172245 | Recruiting | Phase 1 | Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer | September 19, 2022 | June 1, 2026 |
NCT03921684 | Recruiting | Phase 2 | Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | April 2019 | October 2025 |
NCT03921008 | Recruiting | Phase 1/Phase 2 | Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma | May 21, 2019 | August 31, 2027 |
NCT04525989 | Recruiting | N/A | Preoperative Short-Course Radiation Therapy With PROtons Compared to Photons In High-Risk RECTal Cancer (PRORECT) | April 20, 2021 | March 2028 |
NCT03180268 | Recruiting | Phase 3 | Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery | June 14, 2017 | August 31, 2027 |
NCT04539808 | Recruiting | Phase 2 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | May 27, 2021 | October 5, 2025 |
NCT06369610 | Recruiting | Phase 2 | Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer | April 22, 2024 | April 22, 2027 |
NCT05076513 | Recruiting | Early Phase 1 | Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma | October 29, 2021 | February 2025 |
NCT05083754 | Recruiting | Phase 1 | Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma | August 31, 2022 | January 2027 |
NCT06306924 | Recruiting | UNC Metastatic Cancer Radiation Therapy Registry | April 21, 2024 | May 2033 | |
NCT06172296 | Recruiting | Phase 3 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma | April 19, 2024 | December 31, 2029 |
NCT06140407 | Recruiting | Phase 2 | Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer | May 8, 2024 | May 31, 2029 |
NCT04879940 | Recruiting | Phase 2 | Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization | February 23, 2022 | August 1, 2024 |
NCT04892173 | Recruiting | Phase 3 | NBTXR3 With or Without Cetuximab in LA-HNSCC | January 5, 2022 | January 2026 |
NCT06129747 | Recruiting | Phase 2 | Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast | November 30, 2023 | August 9, 2029 |
NCT04894188 | Recruiting | N/A | Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer | January 27, 2022 | July 1, 2041 |
NCT04902040 | Recruiting | Phase 1/Phase 2 | Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies | April 14, 2021 | June 1, 2025 |
NCT03423628 | Recruiting | Phase 1 | A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer | April 2, 2018 | April 22, 2026 |
NCT03398161 | Recruiting | Phase 2 | Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides | January 6, 2018 | December 31, 2024 |
NCT03391869 | Recruiting | Phase 3 | Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | December 29, 2017 | December 31, 2025 |
NCT04947254 | Recruiting | Phase 2 | Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer | August 5, 2021 | June 7, 2026 |
NCT04229459 | Recruiting | Phase 2 | Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | December 30, 2019 | June 2027 |
NCT04030260 | Recruiting | Phase 2 | Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer | July 19, 2019 | July 19, 2023 |
NCT03383094 | Recruiting | Phase 2 | Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer | March 15, 2018 | June 2025 |
NCT06116786 | Recruiting | Phase 1 | A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer | November 27, 2023 | July 27, 2028 |
NCT04984343 | Recruiting | Phase 2 | Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer | February 11, 2022 | December 31, 2027 |
NCT04025372 | Recruiting | Phase 2 | INTREPId (INTermediate Risk Erection PreservatIon Trial) | June 1, 2020 | March 1, 2028 |
NCT04994132 | Recruiting | Phase 3 | A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma | September 14, 2021 | September 30, 2027 |
NCT04997018 | Recruiting | Phase 2 | A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer | August 4, 2021 | August 4, 2026 |
NCT06065449 | Recruiting | Phase 3 | A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases | January 24, 2024 | June 27, 2027 |
NCT06064097 | Recruiting | Phase 2 | A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) | January 17, 2025 | August 31, 2026 |
NCT06037863 | Recruiting | N/A | Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial | September 19, 2023 | September 19, 2028 |
NCT04477200 | Recruiting | Phase 1 | Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma | August 5, 2020 | October 2027 |
NCT03987386 | Recruiting | Phase 3 | Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer | May 30, 2019 | November 1, 2025 |
NCT04151940 | Recruiting | N/A | PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer | September 26, 2019 | November 30, 2026 |
NCT05009992 | Recruiting | Phase 2 | Combination Therapy for the Treatment of Diffuse Midline Gliomas | October 20, 2021 | June 30, 2029 |
NCT03968406 | Recruiting | Phase 1 | Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers | September 26, 2019 | October 1, 2024 |
NCT04505267 | Recruiting | Phase 1 | NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer | February 10, 2021 | March 31, 2026 |
NCT03959085 | Recruiting | Phase 3 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy | October 31, 2019 | March 31, 2030 |
NCT05024097 | Recruiting | Phase 2 | A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer. | March 31, 2022 | December 2027 |
NCT05030298 | Recruiting | Phase 1/Phase 2 | Preoperative Radiosurgery for the Treatment of High Grade Glioma, The NeoGlioma Study | May 23, 2023 | September 15, 2025 |
NCT03945721 | Recruiting | Phase 1 | A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients | July 11, 2019 | December 31, 2026 |
NCT03257163 | Recruiting | Phase 2 | Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer | September 29, 2017 | December 31, 2025 |
NCT04513717 | Recruiting | Phase 3 | Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial | December 15, 2020 | December 31, 2033 |
NCT04391049 | Recruiting | Phase 1 | Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery | June 29, 2020 | October 1, 2025 |
NCT05039632 | Recruiting | Phase 1/Phase 2 | Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies | May 8, 2023 | February 1, 2026 |
NCT05050084 | Recruiting | Phase 3 | Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score | November 3, 2021 | April 30, 2037 |
NCT05050162 | Recruiting | Phase 2/Phase 3 | Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer | October 27, 2021 | February 9, 2036 |
NCT06004336 | Recruiting | Phase 2 | A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs) | October 31, 2023 | January 1, 2029 |
NCT03213925 | Recruiting | Phase 2 | Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer | June 1, 2017 | July 1, 2025 |
NCT03604991 | Suspended | Phase 2/Phase 3 | Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery | May 3, 2019 | January 31, 2026 |
NCT03197506 | Suspended | Phase 2 | Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma | September 15, 2017 | August 31, 2024 |
NCT03712605 | Suspended | Phase 3 | Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial | November 15, 2018 | December 31, 2025 |
NCT03958383 | Suspended | Phase 1/Phase 2 | IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma | January 30, 2020 | August 15, 2025 |
NCT05382338 | Suspended | Phase 3 | A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss | February 20, 2023 | December 20, 2027 |
NCT00002696 | Suspended | Phase 3 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | October 1995 | |
NCT05501665 | Suspended | Phase 1/Phase 2 | Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer | May 9, 2023 | February 1, 2027 |
NCT04751370 | Suspended | Phase 2 | Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer | February 8, 2022 | December 31, 2026 |
NCT00003040 | Terminated | Phase 2 | S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx | September 1997 | December 2007 |
NCT04381988 | Terminated | Phase 2 | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | May 7, 2020 | April 21, 2021 |
NCT00882583 | Terminated | Phase 1 | A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC | July 2009 | February 2016 |
NCT00897377 | Terminated | Phase 3 | Treatment Strategy for Low-grade Gliomas | December 2007 | |
NCT04406857 | Terminated | Phase 1 | Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer | March 17, 2021 | January 18, 2023 |
NCT00915694 | Terminated | Phase 1 | Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme | April 2009 | December 2015 |
NCT00054067 | Terminated | Phase 3 | Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix | February 2003 | |
NCT04457245 | Terminated | Phase 3 | Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer | August 14, 2020 | January 10, 2023 |
NCT00948688 | Terminated | Phase 1/Phase 2 | Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas | August 2009 | November 2013 |
NCT00955240 | Terminated | Phase 2 | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | March 2009 | November 26, 2010 |
NCT00002899 | Terminated | Phase 3 | Adjuvant Radiation Therapy in Treating Patients With Brain Metastases | November 1996 | |
NCT00053014 | Terminated | Phase 2 | S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia | April 2003 | June 2006 |
NCT00002772 | Terminated | Phase 3 | S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | July 1996 | February 2004 |
NCT01134601 | Terminated | Phase 1 | A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum | May 24, 2010 | October 22, 2012 |
NCT01167192 | Terminated | Phase 2 | Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer | February 2011 | September 2016 |
NCT01186406 | Terminated | Phase 2 | Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) | April 2011 | June 16, 2014 |
NCT01197664 | Terminated | Phase 1 | Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery | August 2010 | April 2014 |
NCT01240304 | Terminated | Phase 2 | A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas | November 2010 | October 2019 |
NCT00045617 | Terminated | Phase 2 | S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer | January 2003 | May 2003 |
NCT01305772 | Terminated | Phase 2 | Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN | January 2011 | May 2012 |
NCT01307956 | Terminated | Phase 2 | Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer | February 28, 2011 | December 23, 2015 |
NCT01324141 | Terminated | Phase 1 | Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer | March 18, 2011 | April 15, 2015 |
NCT00042835 | Terminated | Phase 1 | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | May 2002 | |
NCT01373463 | Terminated | Phase 1 | Cisplatin and Pemetrexed With Radiation Followed by Lobectomy | May 2011 | June 2012 |
NCT01400672 | Terminated | Phase 1 | Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma | July 17, 2012 | October 8, 2018 |
NCT00041288 | Terminated | Phase 2 | Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL | October 2001 | January 2003 |
NCT01417403 | Terminated | Phase 1 | Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases | August 2011 | July 2014 |
NCT01427322 | Terminated | Early Phase 1 | Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease | September 2011 | July 2015 |
NCT01441115 | Terminated | Phase 1 | ECI301 and Radiation for Advanced or Metastatic Cancer | September 6, 2011 | April 24, 2013 |
NCT01461772 | Terminated | Phase 3 | Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer | December 2009 | May 2014 |
NCT01508117 | Terminated | Phase 2 | Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients | August 2011 | October 2012 |
NCT01682031 | Terminated | Phase 2 | Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy | June 2009 | June 2012 |
NCT01689974 | Terminated | Phase 2 | Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma | January 2013 | March 2015 |
NCT01693276 | Terminated | Phase 1/Phase 2 | Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer | September 2012 | June 2014 |
NCT01729923 | Terminated | Phase 2 | A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer | March 2013 | September 6, 2016 |
NCT00033449 | Terminated | Phase 1 | Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | February 2002 | |
NCT01754519 | Terminated | Phase 2 | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery | May 2013 | August 2015 |
NCT01758458 | Terminated | Phase 1/Phase 2 | Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma | February 2013 | May 2016 |
NCT01760941 | Terminated | N/A | Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients | March 2013 | June 2015 |
NCT01767935 | Terminated | N/A | Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases | July 2014 | December 2014 |
NCT01769222 | Terminated | Phase 1 | Ipilimumab and Local Radiation for Selected Solid Tumors | February 2013 | June 2015 |
NCT01769508 | Terminated | Phase 2 | Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | February 2013 | February 2015 |
NCT00031798 | Terminated | Phase 3 | Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors | April 1, 2002 | May 1, 2006 |
NCT01822275 | Terminated | Phase 2 | Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme | May 2013 | September 2019 |
NCT01822496 | Terminated | Phase 2 | Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | November 4, 2013 | June 4, 2018 |
NCT00031577 | Terminated | Phase 1 | Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | August 1999 | September 2006 |
NCT01851161 | Terminated | Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy | May 2010 | September 2015 | |
NCT00030511 | Terminated | Phase 2 | Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer | October 2001 | |
NCT00028704 | Terminated | Phase 3 | Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy | October 2001 | |
NCT01868503 | Terminated | Phase 2 | Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer | July 2013 | July 2015 |
NCT05110781 | Terminated | Phase 2 | Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site | December 7, 2021 | April 18, 2023 |
NCT02046187 | Terminated | Phase 1/Phase 2 | Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma | October 2013 | February 2017 |
NCT00088881 | Terminated | Phase 2 | Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma | December 2004 | March 2011 |
NCT00089544 | Terminated | Phase 2 | Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall | June 17, 2004 | November 5, 2013 |
NCT00025298 | Terminated | Phase 2 | Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx | July 2001 | |
NCT00093652 | Terminated | Phase 1/Phase 2 | Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | May 2003 | |
NCT02243007 | Terminated | Phase 2 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | September 2014 | June 2016 |
NCT00104936 | Terminated | Phase 3 | Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery | December 2004 | |
NCT00081224 | Terminated | Phase 2 | Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum | December 2004 | November 2010 |
NCT00107471 | Terminated | Phase 1/Phase 2 | Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma | October 2005 | |
NCT00021112 | Terminated | Phase 2 | Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer | April 2001 | |
NCT02266147 | Terminated | Phase 1/Phase 2 | Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma | October 2014 | April 2017 |
NCT00109850 | Terminated | Phase 2 | S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | May 2005 | May 2012 |
NCT00113386 | Terminated | Phase 3 | Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer | April 2005 | |
NCT00113399 | Terminated | Phase 3 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | April 2005 | |
NCT00020839 | Terminated | Phase 3 | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain | April 2001 | |
NCT00118053 | Terminated | Phase 2 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer | April 2005 | December 2008 |
NCT02392377 | Terminated | Phase 2 | Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy | February 2015 | December 2015 |
NCT00017277 | Terminated | Phase 3 | Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer | March 2001 | |
NCT00158886 | Terminated | Phase 1 | Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer | November 8, 2001 | August 11, 2006 |
NCT00017173 | Terminated | Phase 2 | S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat | February 2003 | July 2011 |
NCT02470533 | Terminated | Phase 2 | Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma | April 30, 2015 | April 30, 2020 |
NCT00016276 | Terminated | Phase 3 | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | May 2001 | |
NCT00014326 | Terminated | Phase 3 | Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma | January 2001 | |
NCT02530502 | Terminated | Phase 1 | Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma | September 30, 2015 | February 12, 2020 |
NCT00194792 | Terminated | Phase 2 | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | August 2005 | July 2011 |
NCT00195078 | Terminated | Phase 1/Phase 2 | Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer | April 2004 | September 2006 |
NCT02538471 | Terminated | Phase 2 | LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer | August 10, 2015 | February 20, 2019 |
NCT00014196 | Terminated | Phase 2 | S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer | March 2001 | March 2005 |
NCT02584829 | Terminated | Phase 1/Phase 2 | Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma | November 6, 2015 | December 18, 2018 |
NCT00238277 | Terminated | Phase 2 | Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme | February 15, 2005 | December 11, 2007 |
NCT00006994 | Terminated | Phase 3 | S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat | November 2001 | April 2006 |
NCT00238615 | Terminated | Phase 2 | Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC | March 2003 | November 2014 |
NCT00006916 | Terminated | Phase 2 | Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme | June 2001 | December 2005 |
NCT00243009 | Terminated | Phase 2 | Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery | June 2005 | April 2006 |
NCT00006472 | Terminated | Phase 2 | Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | January 2000 | September 10, 2002 |
NCT00253552 | Terminated | N/A | G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders | May 2004 | May 2006 |
NCT00255684 | Terminated | N/A | Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer | December 2003 | June 2016 |
NCT00262951 | Terminated | Phase 2 | Chemoradiation in Locally Advanced Pancreatic Cancer | January 2005 | August 2011 |
NCT02911922 | Terminated | N/A | Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer | September 2016 | April 17, 2018 |
NCT00268372 | Terminated | Phase 3 | S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx | December 2005 | December 2007 |
NCT00268437 | Terminated | Phase 2 | Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | April 2006 | March 2015 |
NCT02934503 | Terminated | Phase 2 | Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | January 23, 2017 | October 1, 2019 |
NCT00275106 | Terminated | Phase 3 | Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma | September 2004 | August 2012 |
NCT00280748 | Terminated | Phase 2 | Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer | May 2005 | April 2009 |
NCT00281879 | Terminated | Phase 2 | Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer | February 2006 | March 2008 |
NCT00288054 | Terminated | Phase 1 | S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | April 2006 | April 2012 |
NCT00290628 | Terminated | N/A | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer | October 1999 | April 2007 |
NCT00290719 | Terminated | Phase 1 | Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | November 2005 | June 2008 |
NCT00296010 | Terminated | Phase 3 | Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer | August 2005 | December 2011 |
NCT03168464 | Terminated | Phase 1/Phase 2 | Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) | October 9, 2017 | March 11, 2022 |
NCT00006096 | Terminated | Phase 3 | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva | March 2001 | |
NCT00305643 | Terminated | Phase 3 | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer | February 2006 | October 2008 |
NCT00005987 | Terminated | Phase 2 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | August 2000 | July 2003 |
NCT03246113 | Terminated | Phase 1 | Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma | March 19, 2018 | May 9, 2019 |
NCT03250299 | Terminated | Phase 1 | Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | June 7, 2017 | August 24, 2022 |
NCT00005986 | Terminated | Phase 2 | Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia | August 2000 | |
NCT03277482 | Terminated | Phase 1 | Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer | June 1, 2018 | July 15, 2022 |
NCT00005984 | Terminated | Phase 2 | Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia | August 2000 | September 2005 |
NCT03300544 | Terminated | Phase 1 | Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | May 14, 2019 | March 22, 2022 |
NCT00334763 | Terminated | Phase 2 | Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer | May 2006 | November 2007 |
NCT00005983 | Terminated | Phase 3 | S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer | June 2000 | March 2005 |
NCT00005641 | Terminated | Phase 2 | Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation | September 1997 | September 2000 |
NCT00335959 | Terminated | Phase 2 | S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | May 2006 | |
NCT00348816 | Terminated | Phase 2 | Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer | May 2006 | July 8, 2016 |
NCT00352118 | Terminated | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | March 2006 | April 2008 |
NCT00004897 | Terminated | Phase 2 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | October 1999 | November 2007 |
NCT00356941 | Terminated | Phase 1 | Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC | April 2006 | May 2007 |
NCT00360971 | Terminated | Phase 3 | Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer | July 2006 | February 2009 |
NCT00361621 | Terminated | Phase 2 | Ph II CHOP+Velcade in Mediastinal LBCL | July 2006 | May 2008 |
NCT00004859 | Terminated | Phase 3 | Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer | January 2000 | March 2010 |
NCT00004227 | Terminated | Phase 3 | Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx | April 1999 | May 2008 |
NCT00388804 | Terminated | Phase 3 | External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | February 2005 | April 2011 |
NCT00077103 | Terminated | Phase 1/Phase 2 | Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer | November 2003 | December 2007 |
NCT03486197 | Terminated | Phase 2 | Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma | January 17, 2019 | May 1, 2024 |
NCT03490760 | Terminated | Phase 2 | Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas | November 9, 2018 | July 9, 2020 |
NCT00004093 | Terminated | Phase 1/Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | August 1999 | March 2002 |
NCT00003803 | Terminated | Phase 3 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed | February 1999 | |
NCT00469937 | Terminated | Phase 1 | Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases | February 2006 | March 2009 |
NCT00471653 | Terminated | Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy | November 11, 2006 | August 18, 2009 | |
NCT00068770 | Terminated | Phase 2 | Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT | October 2003 | May 2006 |
NCT00493025 | Terminated | Phase 2 | Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | April 2005 | March 2013 |
NCT03634800 | Terminated | Phase 2 | Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M) | October 23, 2018 | January 16, 2020 |
NCT03649841 | Terminated | Phase 2 | Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer | June 29, 2020 | February 1, 2023 |
NCT03655080 | Terminated | Phase 2 | Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression | January 9, 2019 | June 15, 2021 |
NCT00500890 | Terminated | Phase 3 | Treatment of Tumors of the Choroid Plexus Epithelium | September 2, 2005 | December 14, 2017 |
NCT00068744 | Terminated | Phase 2/Phase 3 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | July 2003 | |
NCT00003777 | Terminated | Phase 2 | Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | December 1998 | April 20, 2001 |
NCT00526890 | Terminated | Phase 2 | Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | October 2006 | September 2010 |
NCT00530634 | Terminated | Phase 2 | Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer | August 1999 | June 2013 |
NCT00540969 | Terminated | Phase 3 | Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases | February 2008 | January 2010 |
NCT03705351 | Terminated | Phase 1 | Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM | December 2, 2019 | February 24, 2022 |
NCT00541112 | Terminated | Phase 2 | Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery | October 29, 2007 | January 29, 2010 |
NCT00543335 | Terminated | Phase 1 | Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer | January 25, 2008 | January 2011 |
NCT00068666 | Terminated | Phase 2 | Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System | January 2004 | March 2010 |
NCT00544648 | Terminated | Phase 1/Phase 2 | Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC | November 2007 | April 2014 |
NCT00544778 | Terminated | Phase 2 | Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma | August 2001 | |
NCT00066417 | Terminated | Phase 2 | Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia | January 2007 | |
NCT00003642 | Terminated | Phase 2 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | October 1998 | |
NCT00570531 | Terminated | Phase 2 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | June 2007 | June 2013 |
NCT00573131 | Terminated | Phase 2 | Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer | January 2008 | November 2010 |
NCT00003640 | Terminated | Phase 2 | Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | September 1998 | |
NCT00603408 | Terminated | Phase 2 | Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer | December 2007 | December 2009 |
NCT00618917 | Terminated | Phase 1/Phase 2 | MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) | November 11, 2005 | August 11, 2011 |
NCT00625183 | Terminated | Phase 2 | Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma | March 2008 | December 2009 |
NCT00062335 | Terminated | Phase 1 | High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | April 2003 | |
NCT00651326 | Terminated | Phase 3 | Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer | June 2, 2008 | January 18, 2011 |
NCT00662311 | Terminated | Phase 1/Phase 2 | Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery | March 2008 | September 2011 |
NCT00664105 | Terminated | Phase 2 | Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC) | February 2004 | June 2008 |
NCT03988647 | Terminated | Phase 2 | Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma | July 24, 2019 | January 20, 2021 |
NCT00707161 | Terminated | Phase 2 | Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma | September 2005 | February 2010 |
NCT00060385 | Terminated | Phase 2/Phase 3 | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma | March 2003 | |
NCT00720083 | Terminated | Phase 2 | Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer | November 2008 | August 2011 |
NCT00732303 | Terminated | Phase 2 | Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer | January 2009 | December 2010 |
NCT04106362 | Terminated | Phase 2 | Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma | January 14, 2020 | May 23, 2023 |
NCT00745134 | Terminated | Phase 2 | Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer | August 11, 2008 | November 11, 2022 |
NCT00745732 | Terminated | Phase 1 | Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC) | October 9, 2008 | September 2012 |
NCT00766636 | Terminated | Phase 2 | Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | September 2008 | |
NCT00776100 | Terminated | Phase 2 | Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | October 2008 | September 2010 |
NCT00788125 | Terminated | Phase 1/Phase 2 | Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors | September 3, 2008 | July 30, 2022 |
NCT00003152 | Terminated | Phase 3 | Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma | March 1997 | |
NCT04199754 | Terminated | Early Phase 1 | IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy | October 1, 2020 | May 28, 2021 |
NCT00003113 | Terminated | Phase 2 | Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas | July 1997 | December 2002 |
NCT00808899 | Terminated | Phase 2 | Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma | December 2008 | July 2009 |
NCT00025103 | Unknown status | Phase 2 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | May 2001 | |
NCT01857453 | Unknown status | Phase 2 | Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas | April 10, 2013 | December 2021 |
NCT01503905 | Unknown status | N/A | Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients | December 2011 | December 2021 |
NCT00003815 | Unknown status | Phase 3 | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | June 1994 | |
NCT03553238 | Unknown status | Phase 2/Phase 3 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | February 14, 2016 | August 30, 2020 |
NCT03564704 | Unknown status | Phase 2/Phase 3 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | February 14, 2016 | May 30, 2021 |
NCT00986557 | Unknown status | Phase 2 | T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant | September 2009 | |
NCT00462397 | Unknown status | Phase 2 | Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | June 2005 | |
NCT00875355 | Unknown status | Phase 2 | Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer | November 2007 | |
NCT01461746 | Unknown status | Phase 2 | Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer | October 2011 | December 2017 |
NCT00002858 | Unknown status | Phase 3 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | March 1993 | |
NCT00492687 | Unknown status | Phase 2 | Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas | December 2006 | |
NCT00002884 | Unknown status | Phase 3 | Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | March 1996 | |
NCT00497250 | Unknown status | Phase 1 | Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy | July 2007 | October 2009 |
NCT00003163 | Unknown status | Phase 2 | Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers | September 1997 | |
NCT00766480 | Unknown status | N/A | Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus | January 2007 | |
NCT00003284 | Unknown status | Phase 2 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | January 1998 | |
NCT00509561 | Unknown status | Phase 2/Phase 3 | Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer | February 2008 | |
NCT00514397 | Unknown status | Phase 2 | Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma | January 2008 | |
NCT00003788 | Unknown status | Phase 3 | Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas | April 1998 | |
NCT00003261 | Unknown status | Phase 2 | Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma | May 1997 | |
NCT00526318 | Unknown status | N/A | Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | January 2007 | |
NCT00154440 | Unknown status | Phase 3 | Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation | November 2001 | October 2013 |
NCT00967655 | Unknown status | Phase 2 | Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer | July 2009 | |
NCT01402180 | Unknown status | Phase 2/Phase 3 | Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy | December 2010 | December 2015 |
NCT02464774 | Unknown status | N/A | Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer | July 2015 | |
NCT00020566 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | February 2001 | |
NCT00002531 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | January 1993 | |
NCT00016887 | Unknown status | Phase 3 | Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | December 2000 | |
NCT02500940 | Unknown status | Phase 3 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | May 2015 | May 2021 |
NCT00188149 | Unknown status | Phase 4 | Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET | May 2000 | December 2007 |
NCT00966888 | Unknown status | Phase 3 | Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy | January 2006 | |
NCT00002499 | Unknown status | Phase 2/Phase 3 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia | January 1990 | |
NCT00536952 | Unknown status | Early Phase 1 | Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy | February 2008 | December 2016 |
NCT00814567 | Unknown status | N/A | Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery | May 3, 2007 | September 2020 |
NCT00003251 | Unknown status | Phase 1/Phase 2 | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | December 1997 | |
NCT00768911 | Unknown status | Phase 1 | CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme | October 2008 | June 2011 |
NCT00011921 | Unknown status | Phase 3 | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | September 1997 | |
NCT00058474 | Unknown status | Phase 3 | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer | July 2004 | May 2016 |
NCT00010088 | Unknown status | Phase 2 | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct | January 1999 | |
NCT00010062 | Unknown status | Phase 2 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | October 2000 | |
NCT00008112 | Unknown status | Phase 2 | Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer | June 2000 | |
NCT00008047 | Unknown status | Phase 1/Phase 2 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | August 1999 | |
NCT00003734 | Unknown status | Phase 3 | Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer | December 1998 | |
NCT00003680 | Unknown status | Phase 3 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | November 1998 | |
NCT00003240 | Unknown status | Phase 3 | Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | October 1995 | |
NCT00053872 | Unknown status | Phase 3 | Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma | February 2003 | |
NCT00024271 | Unknown status | Phase 2 | Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | May 2001 | |
NCT00245141 | Unknown status | Phase 2 | Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma | May 2004 | |
NCT00024336 | Unknown status | Phase 2 | Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma | August 1999 | |
NCT00253409 | Unknown status | N/A | Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery | May 2005 | |
NCT00025064 | Unknown status | Phase 2 | Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma | January 2000 | |
NCT02839343 | Unknown status | Phase 2 | Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer | December 2016 | |
NCT00006460 | Unknown status | Phase 1/Phase 2 | Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | August 2000 | |
NCT02891161 | Unknown status | Phase 1/Phase 2 | Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder | November 2016 | March 2022 |
NCT00093665 | Unknown status | Phase 2 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | November 2003 | |
NCT04602013 | Unknown status | Phase 2 | Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma | October 11, 2020 | May 2022 |
NCT00093587 | Unknown status | N/A | Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | August 2004 | |
NCT00002549 | Unknown status | Phase 3 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | November 1993 | |
NCT00003679 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Women With Breast Cancer | November 1998 | |
NCT02052102 | Unknown status | Phase 2 | Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart | October 2014 | March 2017 |
NCT02928575 | Unknown status | Phase 2 | Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma | August 2012 | June 2017 |
NCT00274898 | Unknown status | Phase 2 | Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer | May 2004 | |
NCT00274911 | Unknown status | Phase 2 | Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors | February 2004 | |
NCT00558519 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | March 12, 2008 | |
NCT00006212 | Unknown status | Phase 1 | Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer | November 1999 | |
NCT00275067 | Unknown status | Phase 1/Phase 2 | Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery | May 2005 | May 2021 |
NCT01252459 | Unknown status | Phase 2 | Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme | July 2011 | July 2014 |
NCT00275119 | Unknown status | Phase 2 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | November 2003 | |
NCT00276666 | Unknown status | Phase 2 | Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery | November 2001 | |
NCT00276731 | Unknown status | Phase 3 | Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma | March 1995 | |
NCT00083083 | Unknown status | Phase 2 | Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer | March 2005 | |
NCT02972333 | Unknown status | Phase 3 | Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M | December 2016 | December 2019 |
NCT00025324 | Unknown status | Phase 2 | Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors | December 2000 | |
NCT00025402 | Unknown status | Phase 3 | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | July 1997 | |
NCT05112341 | Unknown status | Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer | June 1, 2021 | October 1, 2023 | |
NCT00281905 | Unknown status | Phase 2 | Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors | June 1992 | |
NCT00084695 | Unknown status | Phase 2 | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases | September 2003 | |
NCT00287950 | Unknown status | N/A | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma | September 1992 | |
NCT00002987 | Unknown status | Phase 3 | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease | January 1997 | |
NCT00002653 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma | September 1993 | |
NCT00028691 | Unknown status | Phase 3 | Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma | December 2002 | |
NCT00030719 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | December 2001 | |
NCT00006030 | Unknown status | Phase 3 | Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer | January 1992 | |
NCT00002701 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | October 1995 | |
NCT00601406 | Unknown status | N/A | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | March 2006 | |
NCT00081029 | Unknown status | Phase 3 | Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia | January 2004 | |
NCT00311857 | Unknown status | Phase 1/Phase 2 | Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) | February 2006 | |
NCT00313521 | Unknown status | Phase 2 | Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors | June 1995 | |
NCT00002702 | Unknown status | Phase 3 | Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx | September 1992 | |
NCT00003637 | Unknown status | Phase 3 | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx | September 1998 | |
NCT00003583 | Unknown status | Phase 2 | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | June 1997 | |
NCT01752205 | Unknown status | Phase 3 | Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma | November 2012 | November 2014 |
NCT00033683 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | February 2001 | |
NCT00003015 | Unknown status | Phase 3 | Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma | January 1997 | |
NCT00047138 | Unknown status | Phase 3 | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | January 2001 | |
NCT00079365 | Unknown status | N/A | Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas | May 2001 | |
NCT00334854 | Unknown status | Phase 3 | Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | March 2006 | |
NCT00003437 | Unknown status | Phase 3 | Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | January 1997 | |
NCT04562337 | Unknown status | Phase 2 | A Phase II Clinical Study of SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in Extensive Small Cell Lung Cancer | September 2020 | December 2023 |
NCT00005084 | Unknown status | Phase 2 | Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma | February 1999 | |
NCT00077220 | Unknown status | Phase 3 | Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer | June 2002 | |
NCT00616785 | Unknown status | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | June 2007 | |
NCT00039039 | Unknown status | Phase 3 | Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer | February 2000 | |
NCT00337064 | Unknown status | Phase 1/Phase 2 | Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women | June 2006 | |
NCT00343369 | Unknown status | N/A | Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia | January 2003 | |
NCT00348998 | Unknown status | Phase 2 | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | April 2006 | |
NCT00002989 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome | March 1997 | |
NCT00002481 | Unknown status | Phase 2 | Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | March 1990 | |
NCT01711697 | Unknown status | Phase 1 | An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | September 4, 2012 | May 31, 2022 |
NCT04959500 | Unknown status | Phase 2 | Newly Diagnosed Glioblastoma | June 10, 2021 | October 31, 2023 |
NCT00360750 | Unknown status | N/A | Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye | September 2005 | |
NCT00360854 | Unknown status | Phase 1 | Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma | May 2005 | |
NCT00360945 | Unknown status | Phase 2 | Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma | April 2004 | |
NCT00625937 | Unknown status | Phase 2 | Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | November 2006 | |
NCT00626730 | Unknown status | Phase 2 | Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma | December 2007 | |
NCT01671891 | Unknown status | Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer | February 2012 | February 2013 | |
NCT00811408 | Unknown status | Phase 1 | Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy | April 2008 | |
NCT00004253 | Unknown status | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery | March 2000 | |
NCT00077168 | Unknown status | Phase 2 | Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole | April 2004 | |
NCT00379457 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | June 2006 | |
NCT00629278 | Unknown status | Phase 3 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | December 2007 | |
NCT00383695 | Unknown status | Phase 2 | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer | September 2005 | |
NCT00004226 | Unknown status | Phase 1/Phase 2 | Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy | May 2000 | |
NCT00004219 | Unknown status | Phase 3 | Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma | ||
NCT00002771 | Unknown status | Phase 3 | Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | January 1995 | |
NCT00002658 | Unknown status | Phase 3 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | January 1994 | |
NCT03432780 | Unknown status | Phase 2 | Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer | December 18, 2008 | November 14, 2023 |
NCT00039338 | Unknown status | Phase 3 | Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | March 2002 | |
NCT00392886 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors | March 2004 | |
NCT00004164 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | August 1999 | |
NCT00398489 | Unknown status | Phase 2 | Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | October 2006 | |
NCT01546376 | Unknown status | Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients | August 2009 | ||
NCT00637637 | Unknown status | Phase 2 | External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases | September 2007 | |
NCT01048216 | Unknown status | N/A | Partial Liver Radiotherapy for Unresectable Liver Metastases | November 2006 | June 2008 |
NCT00075556 | Unknown status | Phase 2 | Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma | January 2002 | |
NCT00004128 | Unknown status | Phase 3 | Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | September 1999 | |
NCT00410631 | Unknown status | Phase 3 | Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | October 2004 | |
NCT00416377 | Unknown status | N/A | Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma | ||
NCT00416676 | Unknown status | Phase 3 | Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma | ||
NCT00004097 | Unknown status | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | August 1999 | |
NCT00417014 | Unknown status | N/A | Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | ||
NCT00417053 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant | ||
NCT00004094 | Unknown status | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | August 1999 | |
NCT00425425 | Unknown status | Phase 1/Phase 2 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | July 2006 | May 2015 |
NCT00041210 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | October 2001 | |
NCT01005758 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | January 2009 | |
NCT03196401 | Withdrawn | Phase 1 | A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma | July 27, 2017 | June 2020 |
NCT00024128 | Withdrawn | Phase 2 | Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma | August 2001 | March 2003 |
NCT01843738 | Withdrawn | Phase 1 | Radiation Use During Vemurafenib Treatment | June 2017 | August 2022 |
NCT06137651 | Withdrawn | Phase 1 | Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis | December 31, 2023 | March 27, 2024 |
NCT00005998 | Withdrawn | Phase 2 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | January 2000 | March 2003 |
NCT01233479 | Withdrawn | N/A | Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy | May 2010 | August 24, 2017 |
NCT03220009 | Withdrawn | Phase 2 | Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma | November 3, 2017 | July 1, 2021 |
NCT01836341 | Withdrawn | Phase 1 | Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation | April 2013 | April 2015 |
NCT00600210 | Withdrawn | Phase 2 | Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer | January 2008 | April 2011 |
NCT03235869 | Withdrawn | Early Phase 1 | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma | March 1, 2018 | March 1, 2023 |
NCT00310128 | Withdrawn | Phase 2 | Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma | February 2006 | |
NCT02885727 | Withdrawn | Phase 2 | Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) | July 2017 | December 2022 |
NCT03872505 | Withdrawn | Phase 2 | Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer | July 2022 | July 2027 |
NCT00256841 | Withdrawn | Phase 1/Phase 2 | Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy | September 2005 | October 2007 |
NCT01326468 | Withdrawn | N/A | Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer | January 2011 | |
NCT00428194 | Withdrawn | Phase 1 | Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer | January 2007 | March 2008 |
NCT05037019 | Withdrawn | N/A | SIGNAL During a COVID-19 Pandemic | May 2020 | November 2022 |
NCT04854044 | Withdrawn | Phase 1 | ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma | May 1, 2021 | July 1, 2026 |
NCT01796444 | Withdrawn | Phase 3 | Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node | January 2013 | June 2026 |
NCT00006451 | Withdrawn | Phase 3 | Bone Marrow Transplantation in Treating Patients With Leukemia | April 1996 | November 2000 |
NCT00084435 | Withdrawn | Phase 2 | S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer | July 2005 | January 2007 |
NCT00003929 | Withdrawn | Phase 2 | Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma | June 1998 | |
NCT02535988 | Withdrawn | Phase 2 | Abscopal Effect for Metastatic Colorectal Cancer | September 2015 | December 2017 |
NCT02044601 | Withdrawn | Phase 1/Phase 2 | Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | June 2014 | |
NCT00258466 | Withdrawn | Phase 3 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | May 2005 | November 2006 |
NCT00452920 | Withdrawn | Phase 1/Phase 2 | Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer | September 2003 | June 2009 |
NCT05711628 | Withdrawn | Phase 3 | A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma | August 10, 2023 | June 30, 2028 |
NCT00334867 | Withdrawn | Phase 3 | Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma | December 2005 | |
NCT04105374 | Withdrawn | Phase 2/Phase 3 | Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma | January 31, 2020 | November 30, 2030 |
NCT02586610 | Withdrawn | Phase 2 | Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer | October 2016 | December 2020 |
NCT04756505 | Withdrawn | Phase 1 | Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial | March 7, 2021 | February 16, 2022 |
NCT01465815 | Withdrawn | Phase 1/Phase 2 | Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) | December 2011 | September 2013 |
NCT03758729 | Withdrawn | Phase 2 | Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma. | May 2020 | May 11, 2020 |
NCT00025519 | Withdrawn | Phase 2 | Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer | June 2001 | October 2006 |
NCT04995536 | Withdrawn | Phase 1 | CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL | July 27, 2021 | January 4, 2024 |
NCT00006344 | Withdrawn | Phase 3 | Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer | May 2000 | December 2000 |
NCT03977311 | Withdrawn | N/A | MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer | December 31, 2021 | February 28, 2026 |
NCT01087580 | Withdrawn | Phase 2 | Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer | March 2011 | July 2011 |
NCT03628144 | Withdrawn | Phase 2 | Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer | July 2020 | September 2023 |
NCT00006126 | Withdrawn | Phase 1 | Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery | September 1999 | April 2001 |
NCT01301612 | Withdrawn | Phase 2 | Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) | January 2011 | |
NCT02662634 | Withdrawn | Phase 2 | A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer | March 2016 | March 2018 |
NCT00621036 | Withdrawn | Phase 2 | Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma | October 19, 2007 | December 8, 2008 |
NCT00002999 | Withdrawn | Phase 2 | S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx | ||
NCT00055887 | Withdrawn | Phase 3 | Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer | November 2002 | |
NCT03388931 | Withdrawn | Phase 4 | Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx | February 4, 2019 | May 6, 2019 |
NCT00268255 | Withdrawn | Phase 1/Phase 2 | Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | ||
NCT00960427 | Withdrawn | Phase 1 | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | June 2009 | April 2010 |
NCT00903942 | Withdrawn | Phase 2 | Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) | March 2008 | |
NCT01432314 | Withdrawn | Phase 2 | Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) | October 2011 | June 2014 |
NCT00003273 | Withdrawn | Phase 2 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor | November 1997 | |
NCT04585932 | Withdrawn | Phase 2 | Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study | November 24, 2020 | January 8, 2021 |
NCT04917640 | Withdrawn | Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT) | June 2021 | December 2024 | |
NCT00085449 | Withdrawn | Phase 1/Phase 2 | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer | May 2006 | January 2007 |
NCT01416961 | Withdrawn | Phase 1 | Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) | August 2011 | December 2011 |
NCT00734773 | Withdrawn | Early Phase 1 | Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL | November 2008 | |
NCT02976441 | Withdrawn | Early Phase 1 | Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas | January 2017 | February 2018 |
NCT02376413 | Withdrawn | Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients | March 2015 | December 2022 | |
NCT00118300 | Withdrawn | Phase 1 | Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | April 2005 | |
NCT00137358 | Withdrawn | Phase 1 | Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer | ||
NCT03419130 | Withdrawn | Phase 2 | Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer | July 18, 2018 | December 31, 2022 |
NCT00019409 | Withdrawn | Phase 3 | Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia | October 1999 | July 2001 |
NCT05233696 | Withdrawn | Phase 2 | Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC | January 4, 2022 | December 1, 2022 |
NCT00560495 | Withdrawn | Phase 1 | Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | May 2007 | July 2008 |
NCT03146039 | Withdrawn | Phase 2 | Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB | June 2, 2017 | May 15, 2019 |
NCT00003435 | Withdrawn | Phase 1 | Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer | May 1998 | |
NCT00769990 | Withdrawn | Phase 1/Phase 2 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | September 2008 | April 2010 |
NCT02368106 | Withdrawn | Prospective Patient Registry for Radiation Oncology Techniques and Quality | February 2018 | December 2030 | |
NCT03834571 | Withdrawn | Phase 2 | Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women | May 31, 2022 | January 2025 |
NCT00017160 | Withdrawn | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma | ||
NCT03150836 | Withdrawn | Phase 2 | Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer | October 1, 2017 | September 1, 2024 |
NCT00081055 | Withdrawn | Phase 2 | OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies | ||
NCT03488810 | Withdrawn | Phase 3 | Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer | March 10, 2020 | June 15, 2026 |
NCT01345084 | Withdrawn | Phase 3 | Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab | November 2013 | November 2017 |
NCT04607642 | Withdrawn | Phase 2 | Trial of BMX-001 or Placebo in Head and Neck Cancer Patients | July 2021 | July 2025 |
NCT00101140 | Withdrawn | Phase 2 | Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission | ||
NCT02850419 | Withdrawn | Phase 2 | Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients | March 2017 | February 2020 |
NCT00070434 | Withdrawn | Phase 2 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | August 2004 | |
NCT00530205 | Withdrawn | Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer | February 2007 | ||
NCT00547443 | Withdrawn | Phase 1/Phase 2 | Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | July 2007 | July 2009 |